activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650612	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1650612	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1650613	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1650614	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3831	Homo sapiens	Kd		
	1650615	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	320.0	CHEMBL3831	Homo sapiens	Kd	uM	0.32
Not Active	1650616	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3831	Homo sapiens	Kd		
	1650617	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2300.0	CHEMBL3831	Homo sapiens	Kd	uM	2.3
Not Active	1650618	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1650619	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1650620	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3831	Homo sapiens	Kd		
	1651896	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.1	CHEMBL3831	Homo sapiens	Kd	uM	0.0001
Not Active	1651897	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1651898	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1651899	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1651900	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL3831	Homo sapiens	Kd		
	1651901	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	1800.0	CHEMBL3831	Homo sapiens	Kd	uM	1.8
Not Active	1651902	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1651903	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1651904	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1651905	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL3831	Homo sapiens	Kd		
Not Active	1651906	CHEMBL860785	Average Binding Constant for MARK2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL3831	Homo sapiens	Kd		
	1723163	CHEMBL860207	Inhibition of EMK	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	7500.0	CHEMBL3831	Homo sapiens	Ki	nM	7500.0
	1723164	CHEMBL860207	Inhibition of EMK	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	7500.0	CHEMBL3831	Homo sapiens	Ki	nM	7500.0
	1723165	CHEMBL860207	Inhibition of EMK	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	7500.0	CHEMBL3831	Homo sapiens	Ki	nM	7500.0
	1723166	CHEMBL860207	Inhibition of EMK	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	7500.0	CHEMBL3831	Homo sapiens	Ki	nM	7500.0
	1723167	CHEMBL860207	Inhibition of EMK	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	7500.0	CHEMBL3831	Homo sapiens	Ki	nM	7500.0
	1723168	CHEMBL860207	Inhibition of EMK	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	7500.0	CHEMBL3831	Homo sapiens	Ki	nM	7500.0
	1744481	CHEMBL867307	Inhibition of EMK	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	7500.0	CHEMBL3831	Homo sapiens	Ki	uM	7.5
	1824537	CHEMBL913850	Inhibition of EMK	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL3831	Homo sapiens	Ki	uM	10.0
	1824713	CHEMBL913850	Inhibition of EMK	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL3831	Homo sapiens	Ki	uM	10.0
	1824786	CHEMBL913850	Inhibition of EMK	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	7350.0	CHEMBL3831	Homo sapiens	Ki	uM	7.35
	1916295	CHEMBL894156	Inhibition of recombinant EMK by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080	=	IC50	nM	13860.0	CHEMBL3831	Homo sapiens	IC50	uM	13.86
	1916348	CHEMBL894156	Inhibition of recombinant EMK by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL3831	Homo sapiens	IC50	uM	10.0
	1944467	CHEMBL891247	Inhibition of EMK by radiometric assay	B	O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL438485	>	IC50	nM	50000.0	CHEMBL3831	Homo sapiens	IC50	nM	50000.0
	1944468	CHEMBL891247	Inhibition of EMK by radiometric assay	B	O=C(NCc1ccncc1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL242753	=	IC50	nM	4590.0	CHEMBL3831	Homo sapiens	IC50	nM	4590.0
	2051582	CHEMBL942723	Inhibition of EMK	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	4266.0	CHEMBL3831	Homo sapiens	Ki	uM	4.266
	2147337	CHEMBL922022	Activity of human PAR1Balpha kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	101.0	CHEMBL3831	Homo sapiens	Activity	%	101.0
	2470261	CHEMBL987180	Inhibition of MARK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3831	Homo sapiens	INH	%	10.0
Not Evaluated	2476724	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2478563	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3831	Homo sapiens	Activity		
	2478766	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	7.9	CHEMBL3831	Homo sapiens	Activity	%	7.9
	2479621	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	5.3	CHEMBL3831	Homo sapiens	Activity	%	5.3
	2479824	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	19.3	CHEMBL3831	Homo sapiens	Activity	%	19.3
	2480621	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.3	CHEMBL3831	Homo sapiens	Activity	%	0.3
	2480823	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	12.3	CHEMBL3831	Homo sapiens	Activity	%	12.3
	2567268	CHEMBL975455	Inhibition of human PAR-1Balpha kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	42.0	CHEMBL3831	Homo sapiens	Activity	%	42.0
Not Evaluated	2577242	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3831	Homo sapiens	Activity		
	2577445	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	16.6	CHEMBL3831	Homo sapiens	Activity	%	16.6
Not Evaluated	2593650	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2593916	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2594119	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2594859	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2595062	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2596259	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2596462	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3831	Homo sapiens	Activity		
Not Evaluated	2597731	CHEMBL982752	Binding affinity to human MARK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3831	Homo sapiens	Activity		
	2721677	CHEMBL1057488	Inhibition of PAR-1Balpha at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	2900418	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900419	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900420	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900421	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900422	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900423	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900424	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1500.0	CHEMBL3831	Homo sapiens	Kd	nM	1500.0
	2900425	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900426	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900427	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900428	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900429	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900430	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900431	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900432	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900433	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900434	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900435	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900436	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900437	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1200.0	CHEMBL3831	Homo sapiens	Kd	nM	1200.0
	2900438	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900439	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900440	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900441	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900442	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900443	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	100.0	CHEMBL3831	Homo sapiens	Kd	nM	100.0
	2900444	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900445	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900446	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900447	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900448	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900449	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900450	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.7	CHEMBL3831	Homo sapiens	Kd	nM	0.7
	2900451	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	440.0	CHEMBL3831	Homo sapiens	Kd	nM	440.0
	2900452	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3831	Homo sapiens	Kd	nM	310.0
	2900453	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1400.0	CHEMBL3831	Homo sapiens	Kd	nM	1400.0
	2900454	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2900455	CHEMBL1049903	Binding constant for MARK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	2921276	CHEMBL1049123	Inhibition of MARK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	2938467	CHEMBL1041398	Inhibition of PAR-1Balpha at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	5.0	CHEMBL3831	Homo sapiens	INH	%	5.0
	2992227	CHEMBL1044530	Inhibition of human MARK2 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	14.0	CHEMBL3831	Homo sapiens	INH	%	14.0
	3052653	CHEMBL1041140	Residual activity of MARK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL3831	Homo sapiens	Residual activity	%	87.0
	3053962	CHEMBL1050293	Residual activity of MARK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	60.0	CHEMBL3831	Homo sapiens	Residual activity	%	60.0
	3054214	CHEMBL1040682	Residual activity of MARK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	82.0	CHEMBL3831	Homo sapiens	Residual activity	%	82.0
	3055501	CHEMBL1041140	Residual activity of MARK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	74.0	CHEMBL3831	Homo sapiens	Residual activity	%	74.0
	3056806	CHEMBL1050293	Residual activity of MARK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	67.0	CHEMBL3831	Homo sapiens	Residual activity	%	67.0
	3057058	CHEMBL1040682	Residual activity of MARK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	90.0	CHEMBL3831	Homo sapiens	Residual activity	%	90.0
	3058378	CHEMBL1041140	Residual activity of MARK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	86.0	CHEMBL3831	Homo sapiens	Residual activity	%	86.0
	3058630	CHEMBL1050293	Residual activity of MARK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	72.0	CHEMBL3831	Homo sapiens	Residual activity	%	72.0
	3072976	CHEMBL1040682	Residual activity of MARK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL3831	Homo sapiens	Residual activity	%	87.0
	3213961	CHEMBL1116709	Inhibition of MARK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-5.0	CHEMBL3831	Homo sapiens	INH	%	-5.0
	3224882	CHEMBL1100960	Inhibition of MARK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3226261	CHEMBL1100960	Inhibition of MARK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3260064	CHEMBL1104327	Inhibition of MARK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	77.0	CHEMBL3831	Homo sapiens	Activity	%	77.0
	3261409	CHEMBL1104327	Inhibition of MARK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	82.0	CHEMBL3831	Homo sapiens	Activity	%	82.0
	3332017	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3333432	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3334837	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3336257	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3337577	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	=	Inhibition	%	85.0	CHEMBL3831	Homo sapiens	INH	%	85.0
	3338908	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3339161	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3340465	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	72.3	CHEMBL3831	Homo sapiens	INH	%	72.3
	3341799	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	3343246	CHEMBL1166067	Inhibition of MARK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	Inhibition	%	66.0	CHEMBL3831	Homo sapiens	INH	%	66.0
	3358658	CHEMBL1174900	Inhibition of MARK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL3831	Homo sapiens	INH	%	100.0
	3359100	CHEMBL1174900	Inhibition of MARK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	83.0	CHEMBL3831	Homo sapiens	INH	%	83.0
	3409179	CHEMBL1219888	Inhibition of human MARK2	B	NC(=O)c1cc(-c2ccnc(NC3CCCCC3)c2)nc(N2CCNCC2)c1		CHEMBL1214999	=	Inhibition	%	27.0	CHEMBL3831	Homo sapiens	INH	%	27.0
	3409189	CHEMBL1219888	Inhibition of human MARK2	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Inhibition	%	83.0	CHEMBL3831	Homo sapiens	INH	%	83.0
	3443451	CHEMBL1244217	Inhibition of MARK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	11.0	CHEMBL3831	Homo sapiens	INH	%	11.0
	3443668	CHEMBL1244217	Inhibition of MARK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	28.0	CHEMBL3831	Homo sapiens	INH	%	28.0
	3444823	CHEMBL1244217	Inhibition of MARK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	1.0	CHEMBL3831	Homo sapiens	INH	%	1.0
	3445189	CHEMBL1244501	Binding affinity to MARK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	14.0	CHEMBL3831	Homo sapiens	Kd	nM	14.0
	3445447	CHEMBL1244217	Inhibition of MARK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	4.0	CHEMBL3831	Homo sapiens	INH	%	4.0
	3445664	CHEMBL1244217	Inhibition of MARK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	12.0	CHEMBL3831	Homo sapiens	INH	%	12.0
	3448493	CHEMBL1244501	Binding affinity to MARK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	3448981	CHEMBL1244501	Binding affinity to MARK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	100.0	CHEMBL3831	Homo sapiens	Kd	nM	100.0
	3449263	CHEMBL1244501	Binding affinity to MARK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3831	Homo sapiens	Kd	nM	310.0
	3449264	CHEMBL1244501	Binding affinity to MARK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	400.0	CHEMBL3831	Homo sapiens	Kd	nM	400.0
	3449726	CHEMBL1244501	Binding affinity to MARK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	3450130	CHEMBL1244501	Binding affinity to MARK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	uM	10.0
	3463285	CHEMBL1252488	Inhibition of MARK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	68.0	CHEMBL3831	Homo sapiens	INH	%	68.0
	3463829	CHEMBL1252488	Inhibition of MARK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	26.0	CHEMBL3831	Homo sapiens	INH	%	26.0
	3464048	CHEMBL1252488	Inhibition of MARK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	93.0	CHEMBL3831	Homo sapiens	INH	%	93.0
Not Active	3499135	CHEMBL1259879	Inhibition of MARK2 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL3831	Homo sapiens	INH		
	3603114	CHEMBL1291211	Inhibition of MARK2 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	8.0	CHEMBL3831	Homo sapiens	Inihibition	%	8.0
	5120043	CHEMBL1648808	Inhibition of MARK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	1.0	CHEMBL3831	Homo sapiens	INH	%	1.0
	5120044	CHEMBL1648808	Inhibition of MARK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	1.0	CHEMBL3831	Homo sapiens	INH	%	1.0
	5120102	CHEMBL1648808	Inhibition of MARK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	4.0	CHEMBL3831	Homo sapiens	INH	%	4.0
	5120436	CHEMBL1648662	Inhibition of human PAR-1Balpha at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	110.0	CHEMBL3831	Homo sapiens	INH	%	110.0
	5132589	CHEMBL1645821	Inhibition of MARK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	90.0	CHEMBL3831	Homo sapiens	Activity	%	90.0
	5133732	CHEMBL1645821	Inhibition of MARK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	5133939	CHEMBL1645821	Inhibition of MARK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	5139755	CHEMBL1648808	Inhibition of MARK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	-2.0	CHEMBL3831	Homo sapiens	INH	%	-2.0
	5139771	CHEMBL1648808	Inhibition of MARK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	5139772	CHEMBL1648808	Inhibition of MARK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	5249438	CHEMBL1686789	Inhibition of MARK2 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	9.0	CHEMBL3831	Homo sapiens	INH	%	9.0
	6167610	CHEMBL1768470	Binding affinity to human Mark2 isoleucine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	6167632	CHEMBL1768651	Binding affinity to human Mark2 isoleucine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	8.8	CHEMBL3831	Homo sapiens	Activity	%	8.8
	6221267	CHEMBL1787829	Inhibition of MARK2 at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	1.0	CHEMBL3831	Homo sapiens	INH	%	1.0
	6341085	CHEMBL1828398	Activity of MARK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	6352233	CHEMBL1825840	Inhibition of MARK2 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	79.0	CHEMBL3831	Homo sapiens	Activity	%	79.0
	6353467	CHEMBL1825779	Inhibition of MARK2 at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	4.0	CHEMBL3831	Homo sapiens	INH	%	4.0
	7567523	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7567994	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7568462	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	9900.0	CHEMBL3831	Homo sapiens	Kd	nM	9900.0
	7568894	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	440.0	CHEMBL3831	Homo sapiens	Kd	nM	440.0
	7569037	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7569497	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7569969	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7570432	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	3600.0	CHEMBL3831	Homo sapiens	Kd	nM	3600.0
	7570859	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	310.0	CHEMBL3831	Homo sapiens	Kd	nM	310.0
	7571013	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7571470	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7571946	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	660.0	CHEMBL3831	Homo sapiens	Kd	nM	660.0
	7572409	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7572825	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	44.0	CHEMBL3831	Homo sapiens	Kd	nM	44.0
	7572994	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7573451	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7573927	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2300.0	CHEMBL3831	Homo sapiens	Kd	nM	2300.0
	7574972	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1400.0	CHEMBL3831	Homo sapiens	Kd	nM	1400.0
	7575433	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7575904	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7575927	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	100.0	CHEMBL3831	Homo sapiens	Kd	nM	100.0
	7576335	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7576946	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7577405	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7577911	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7578316	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	3100.0	CHEMBL3831	Homo sapiens	Kd	nM	3100.0
	7578954	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7579328	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7579810	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	440.0	CHEMBL3831	Homo sapiens	Kd	nM	440.0
	7580279	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	6200.0	CHEMBL3831	Homo sapiens	Kd	nM	6200.0
	7580682	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7581700	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7582171	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7582635	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7583035	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1400.0	CHEMBL3831	Homo sapiens	Kd	nM	1400.0
	7583216	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7583613	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7584058	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7584529	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7584991	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	280.0	CHEMBL3831	Homo sapiens	Kd	nM	280.0
	7585395	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7585546	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7585954	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7586400	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7586871	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7587325	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7587507	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7587926	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7588379	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7588850	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7589301	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7589472	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7589896	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	14.0	CHEMBL3831	Homo sapiens	Kd	nM	14.0
	7590363	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7590837	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7591445	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7591867	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1500.0	CHEMBL3831	Homo sapiens	Kd	nM	1500.0
	7592339	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7592823	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7593412	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7593847	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7594350	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7594802	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7595380	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7595824	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7595856	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	720.0	CHEMBL3831	Homo sapiens	Kd	nM	720.0
	7596327	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7596774	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7597352	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7597836	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7598306	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3831	Homo sapiens	Kd	nM	10000.0
	7598748	CHEMBL1908803	Binding constant for MARK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.7	CHEMBL3831	Homo sapiens	Kd	nM	0.7
	7961057	CHEMBL1931510	Inhibition of MARK2/PAR-1Balpha	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3831	Homo sapiens	IC50	uM	30.0
	7961058	CHEMBL1931510	Inhibition of MARK2/PAR-1Balpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	43000.0	CHEMBL3831	Homo sapiens	IC50	uM	43.0
	7969746	CHEMBL1931445	Inhibition of MARK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	78.0	CHEMBL3831	Homo sapiens	Activity	%	78.0
	7992205	CHEMBL1935873	Inhibition of MARK2 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	86.0	CHEMBL3831	Homo sapiens	INH	%	86.0
	8047139	CHEMBL1958968	Inhibition of MARK2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	8061273	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.38	CHEMBL3831	Homo sapiens	Inhibition	%	-0.38
	8061450	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	4.82	CHEMBL3831	Homo sapiens	Inhibition	%	4.82
	8061781	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-0.33	CHEMBL3831	Homo sapiens	Inhibition	%	-0.33
	8061972	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.17	CHEMBL3831	Homo sapiens	Inhibition	%	1.17
	8062196	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.73	CHEMBL3831	Homo sapiens	Inhibition	%	5.73
	8062312	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.44	CHEMBL3831	Homo sapiens	Inhibition	%	0.44
	8062698	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.47	CHEMBL3831	Homo sapiens	Inhibition	%	1.47
	8062796	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.6	CHEMBL3831	Homo sapiens	Inhibition	%	1.6
	8063020	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.66	CHEMBL3831	Homo sapiens	Inhibition	%	0.66
	8063152	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.58	CHEMBL3831	Homo sapiens	Inhibition	%	2.58
	8063319	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.27	CHEMBL3831	Homo sapiens	Inhibition	%	-0.27
	8063543	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.83	CHEMBL3831	Homo sapiens	Inhibition	%	-0.83
	8063651	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.01	CHEMBL3831	Homo sapiens	Inhibition	%	-0.01
	8064057	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-1.11	CHEMBL3831	Homo sapiens	Inhibition	%	-1.11
	8064172	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.69	CHEMBL3831	Homo sapiens	Inhibition	%	4.69
	8064606	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.06	CHEMBL3831	Homo sapiens	Inhibition	%	1.06
	8064744	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.48	CHEMBL3831	Homo sapiens	Inhibition	%	1.48
	8065134	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.67	CHEMBL3831	Homo sapiens	Inhibition	%	0.67
	8065250	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.45	CHEMBL3831	Homo sapiens	Inhibition	%	-0.45
	8065474	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.39	CHEMBL3831	Homo sapiens	Inhibition	%	-0.39
	8065649	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.86	CHEMBL3831	Homo sapiens	Inhibition	%	1.86
	8065764	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.56	CHEMBL3831	Homo sapiens	Inhibition	%	0.56
	8065988	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	11.04	CHEMBL3831	Homo sapiens	Inhibition	%	11.04
	8066198	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.35	CHEMBL3831	Homo sapiens	Inhibition	%	0.35
	8066334	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	16.84	CHEMBL3831	Homo sapiens	Inhibition	%	16.84
	8066558	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.81	CHEMBL3831	Homo sapiens	Inhibition	%	2.81
	8066724	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.61	CHEMBL3831	Homo sapiens	Inhibition	%	-0.61
	8067072	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.27	CHEMBL3831	Homo sapiens	Inhibition	%	0.27
	8067247	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-2.72	CHEMBL3831	Homo sapiens	Inhibition	%	-2.72
	8067592	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.63	CHEMBL3831	Homo sapiens	Inhibition	%	-0.63
	8067802	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.67	CHEMBL3831	Homo sapiens	Inhibition	%	1.67
	8068161	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	20.02	CHEMBL3831	Homo sapiens	Inhibition	%	20.02
	8068325	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.17	CHEMBL3831	Homo sapiens	Inhibition	%	-0.17
	8068674	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.6	CHEMBL3831	Homo sapiens	Inhibition	%	0.6
	8068848	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.75	CHEMBL3831	Homo sapiens	Inhibition	%	1.75
	8069197	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.53	CHEMBL3831	Homo sapiens	Inhibition	%	0.53
	8069492	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	4.29	CHEMBL3831	Homo sapiens	Inhibition	%	4.29
	8069653	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.47	CHEMBL3831	Homo sapiens	Inhibition	%	-0.47
	8069877	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.48	CHEMBL3831	Homo sapiens	Inhibition	%	0.48
	8070003	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	Inhibition	%	0.0
	8070175	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.3	CHEMBL3831	Homo sapiens	Inhibition	%	0.3
	8070399	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.02	CHEMBL3831	Homo sapiens	Inhibition	%	2.02
	8070524	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-2.82	CHEMBL3831	Homo sapiens	Inhibition	%	-2.82
	8070822	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	31.61	CHEMBL3831	Homo sapiens	Inhibition	%	31.61
	8071203	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.15	CHEMBL3831	Homo sapiens	Inhibition	%	-0.15
	8071329	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.96	CHEMBL3831	Homo sapiens	Inhibition	%	-0.96
	8071726	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.08	CHEMBL3831	Homo sapiens	Inhibition	%	-0.08
	8071851	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.26	CHEMBL3831	Homo sapiens	Inhibition	%	-0.26
	8072075	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-8.34	CHEMBL3831	Homo sapiens	Inhibition	%	-8.34
	8072165	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.89	CHEMBL3831	Homo sapiens	Inhibition	%	0.89
	8072389	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.86	CHEMBL3831	Homo sapiens	Inhibition	%	0.86
	8072546	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.31	CHEMBL3831	Homo sapiens	Inhibition	%	0.31
	8072671	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.03	CHEMBL3831	Homo sapiens	Inhibition	%	-0.03
	8072895	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-2.4	CHEMBL3831	Homo sapiens	Inhibition	%	-2.4
	8073062	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.09	CHEMBL3831	Homo sapiens	Inhibition	%	2.09
	8073411	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.26	CHEMBL3831	Homo sapiens	Inhibition	%	-0.26
	8073530	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.42	CHEMBL3831	Homo sapiens	Inhibition	%	-0.42
	8073754	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.44	CHEMBL3831	Homo sapiens	Inhibition	%	4.44
	8073987	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.94	CHEMBL3831	Homo sapiens	Inhibition	%	3.94
	8074139	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.9	CHEMBL3831	Homo sapiens	Inhibition	%	-0.9
	8074493	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.58	CHEMBL3831	Homo sapiens	Inhibition	%	-0.58
	8074650	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.48	CHEMBL3831	Homo sapiens	Inhibition	%	1.48
	8075001	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.66	CHEMBL3831	Homo sapiens	Inhibition	%	-0.66
	8075336	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.95	CHEMBL3831	Homo sapiens	Inhibition	%	-1.95
	8075573	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	10.03	CHEMBL3831	Homo sapiens	Inhibition	%	10.03
	8075714	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-2.87	CHEMBL3831	Homo sapiens	Inhibition	%	-2.87
	8075938	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.4	CHEMBL3831	Homo sapiens	Inhibition	%	0.4
	8076080	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.4	CHEMBL3831	Homo sapiens	Inhibition	%	0.4
	8076228	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.22	CHEMBL3831	Homo sapiens	Inhibition	%	2.22
	8076452	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.0	CHEMBL3831	Homo sapiens	Inhibition	%	1.0
	8076586	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.39	CHEMBL3831	Homo sapiens	Inhibition	%	1.39
	8076912	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.44	CHEMBL3831	Homo sapiens	Inhibition	%	2.44
	8077159	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	63.87	CHEMBL3831	Homo sapiens	Inhibition	%	63.87
	8077511	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-1.11	CHEMBL3831	Homo sapiens	Inhibition	%	-1.11
	8077662	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.83	CHEMBL3831	Homo sapiens	Inhibition	%	4.83
	8078029	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.11	CHEMBL3831	Homo sapiens	Inhibition	%	2.11
	8078168	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.4	CHEMBL3831	Homo sapiens	Inhibition	%	0.4
	8078494	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.2	CHEMBL3831	Homo sapiens	Inhibition	%	-1.2
	8078744	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	90.52	CHEMBL3831	Homo sapiens	Inhibition	%	90.52
	8079084	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.87	CHEMBL3831	Homo sapiens	Inhibition	%	0.87
	8079242	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.27	CHEMBL3831	Homo sapiens	Inhibition	%	-0.27
	8079608	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-1.34	CHEMBL3831	Homo sapiens	Inhibition	%	-1.34
	8079747	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	7.38	CHEMBL3831	Homo sapiens	Inhibition	%	7.38
	8079971	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.99	CHEMBL3831	Homo sapiens	Inhibition	%	7.99
	8080076	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.57	CHEMBL3831	Homo sapiens	Inhibition	%	2.57
	8080328	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	25.94	CHEMBL3831	Homo sapiens	Inhibition	%	25.94
	8080667	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.5	CHEMBL3831	Homo sapiens	Inhibition	%	0.5
	8080831	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.76	CHEMBL3831	Homo sapiens	Inhibition	%	4.76
	8081055	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.15	CHEMBL3831	Homo sapiens	Inhibition	%	0.15
	8081190	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.88	CHEMBL3831	Homo sapiens	Inhibition	%	0.88
	8081558	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	41.0	CHEMBL3831	Homo sapiens	Inhibition	%	41.0
	8081661	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.55	CHEMBL3831	Homo sapiens	Inhibition	%	0.55
	8081885	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	16.34	CHEMBL3831	Homo sapiens	Inhibition	%	16.34
	8081913	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	70.54	CHEMBL3831	Homo sapiens	Inhibition	%	70.54
	8082137	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.67	CHEMBL3831	Homo sapiens	Inhibition	%	3.67
	8082250	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.4	CHEMBL3831	Homo sapiens	Inhibition	%	0.4
	8082647	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.75	CHEMBL3831	Homo sapiens	Inhibition	%	1.75
	8082770	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.5	CHEMBL3831	Homo sapiens	Inhibition	%	0.5
	8082994	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.79	CHEMBL3831	Homo sapiens	Inhibition	%	0.79
	8083150	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.13	CHEMBL3831	Homo sapiens	Inhibition	%	1.13
	8083473	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.45	CHEMBL3831	Homo sapiens	Inhibition	%	-1.45
	8083727	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	21.89	CHEMBL3831	Homo sapiens	Inhibition	%	21.89
	8083837	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-1.15	CHEMBL3831	Homo sapiens	Inhibition	%	-1.15
	8084061	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.63	CHEMBL3831	Homo sapiens	Inhibition	%	-0.63
	8084246	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	5.97	CHEMBL3831	Homo sapiens	Inhibition	%	5.97
	8084588	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.19	CHEMBL3831	Homo sapiens	Inhibition	%	0.19
	8084749	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.93	CHEMBL3831	Homo sapiens	Inhibition	%	9.93
	8085071	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.88	CHEMBL3831	Homo sapiens	Inhibition	%	2.88
	8085327	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.79	CHEMBL3831	Homo sapiens	Inhibition	%	1.79
	8085659	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.89	CHEMBL3831	Homo sapiens	Inhibition	%	0.89
	8085848	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	35.32	CHEMBL3831	Homo sapiens	Inhibition	%	35.32
	8086187	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.46	CHEMBL3831	Homo sapiens	Inhibition	%	0.46
	8086349	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.43	CHEMBL3831	Homo sapiens	Inhibition	%	1.43
	8086573	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.87	CHEMBL3831	Homo sapiens	Inhibition	%	2.87
	8086672	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.74	CHEMBL3831	Homo sapiens	Inhibition	%	-1.74
	8086883	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.0	CHEMBL3831	Homo sapiens	Inhibition	%	1.0
	8087107	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.64	CHEMBL3831	Homo sapiens	Inhibition	%	2.64
	8087265	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.59	CHEMBL3831	Homo sapiens	Inhibition	%	0.59
	8087603	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.41	CHEMBL3831	Homo sapiens	Inhibition	%	0.41
	8087741	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.8	CHEMBL3831	Homo sapiens	Inhibition	%	2.8
	8088107	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.03	CHEMBL3831	Homo sapiens	Inhibition	%	2.03
	8088255	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.25	CHEMBL3831	Homo sapiens	Inhibition	%	-0.25
	8088479	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.64	CHEMBL3831	Homo sapiens	Inhibition	%	4.64
	8088607	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.49	CHEMBL3831	Homo sapiens	Inhibition	%	1.49
	8088924	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.79	CHEMBL3831	Homo sapiens	Inhibition	%	2.79
	8089052	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.3	CHEMBL3831	Homo sapiens	Inhibition	%	-0.3
	8089276	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.3	CHEMBL3831	Homo sapiens	Inhibition	%	1.3
	8089424	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.87	CHEMBL3831	Homo sapiens	Inhibition	%	1.87
	8089768	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.4	CHEMBL3831	Homo sapiens	Inhibition	%	1.4
	8089948	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.77	CHEMBL3831	Homo sapiens	Inhibition	%	-0.77
	8090337	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.63	CHEMBL3831	Homo sapiens	Inhibition	%	3.63
	8090504	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.89	CHEMBL3831	Homo sapiens	Inhibition	%	-0.89
	8090867	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-1.1	CHEMBL3831	Homo sapiens	Inhibition	%	-1.1
	8091072	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-0.24	CHEMBL3831	Homo sapiens	Inhibition	%	-0.24
	8091433	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.68	CHEMBL3831	Homo sapiens	Inhibition	%	1.68
	8091588	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.92	CHEMBL3831	Homo sapiens	Inhibition	%	1.92
	8091928	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.48	CHEMBL3831	Homo sapiens	Inhibition	%	3.48
	8092065	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.21	CHEMBL3831	Homo sapiens	Inhibition	%	-1.21
	8092289	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.83	CHEMBL3831	Homo sapiens	Inhibition	%	-1.83
	8092440	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.51	CHEMBL3831	Homo sapiens	Inhibition	%	-0.51
	8092812	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.15	CHEMBL3831	Homo sapiens	Inhibition	%	1.15
	8092941	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.29	CHEMBL3831	Homo sapiens	Inhibition	%	5.29
	8093253	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-1.06	CHEMBL3831	Homo sapiens	Inhibition	%	-1.06
	8093617	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.17	CHEMBL3831	Homo sapiens	Inhibition	%	1.17
	8093756	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	14.16	CHEMBL3831	Homo sapiens	Inhibition	%	14.16
	8094100	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.17	CHEMBL3831	Homo sapiens	Inhibition	%	-0.17
	8094280	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.91	CHEMBL3831	Homo sapiens	Inhibition	%	1.91
	8094504	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.28	CHEMBL3831	Homo sapiens	Inhibition	%	-0.28
	8094679	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.75	CHEMBL3831	Homo sapiens	Inhibition	%	5.75
	8094835	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.71	CHEMBL3831	Homo sapiens	Inhibition	%	0.71
	8095059	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	-0.55	CHEMBL3831	Homo sapiens	Inhibition	%	-0.55
	8095199	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-1.52	CHEMBL3831	Homo sapiens	Inhibition	%	-1.52
	8095402	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.67	CHEMBL3831	Homo sapiens	Inhibition	%	1.67
	8095767	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	14.61	CHEMBL3831	Homo sapiens	Inhibition	%	14.61
	8095915	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.07	CHEMBL3831	Homo sapiens	Inhibition	%	-0.07
	8096139	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.96	CHEMBL3831	Homo sapiens	Inhibition	%	3.96
	8096256	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.95	CHEMBL3831	Homo sapiens	Inhibition	%	0.95
	8096619	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.59	CHEMBL3831	Homo sapiens	Inhibition	%	0.59
	8096775	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.65	CHEMBL3831	Homo sapiens	Inhibition	%	0.65
	8097146	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.63	CHEMBL3831	Homo sapiens	Inhibition	%	4.63
	8097453	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.92	CHEMBL3831	Homo sapiens	Inhibition	%	1.92
	8097677	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.99	CHEMBL3831	Homo sapiens	Inhibition	%	0.99
	8097827	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	13.57	CHEMBL3831	Homo sapiens	Inhibition	%	13.57
	8097960	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.31	CHEMBL3831	Homo sapiens	Inhibition	%	-2.31
	8098184	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.87	CHEMBL3831	Homo sapiens	Inhibition	%	0.87
	8098304	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.23	CHEMBL3831	Homo sapiens	Inhibition	%	-2.23
	8098708	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-1.72	CHEMBL3831	Homo sapiens	Inhibition	%	-1.72
	8098893	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	39.3	CHEMBL3831	Homo sapiens	Inhibition	%	39.3
	8099261	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.39	CHEMBL3831	Homo sapiens	Inhibition	%	2.39
	8099403	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.07	CHEMBL3831	Homo sapiens	Inhibition	%	-0.07
	8099597	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.15	CHEMBL3831	Homo sapiens	Inhibition	%	-0.15
	8099821	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.62	CHEMBL3831	Homo sapiens	Inhibition	%	0.62
	8099968	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.05	CHEMBL3831	Homo sapiens	Inhibition	%	2.05
	8100338	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.73	CHEMBL3831	Homo sapiens	Inhibition	%	1.73
	8100454	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.08	CHEMBL3831	Homo sapiens	Inhibition	%	1.08
	8100678	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-1.85	CHEMBL3831	Homo sapiens	Inhibition	%	-1.85
	8100818	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.27	CHEMBL3831	Homo sapiens	Inhibition	%	2.27
	8100978	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O	Outside typical range	CHEMBL231013	=	Inhibition	%	-12.52	CHEMBL3831	Homo sapiens	Inhibition	%	-12.52
	8101202	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.17	CHEMBL3831	Homo sapiens	Inhibition	%	0.17
	8101344	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.94	CHEMBL3831	Homo sapiens	Inhibition	%	2.94
	8101529	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.63	CHEMBL3831	Homo sapiens	Inhibition	%	-0.63
	8101753	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.49	CHEMBL3831	Homo sapiens	Inhibition	%	0.49
	8102006	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	5.48	CHEMBL3831	Homo sapiens	Inhibition	%	5.48
	8102161	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.92	CHEMBL3831	Homo sapiens	Inhibition	%	0.92
	8102516	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.71	CHEMBL3831	Homo sapiens	Inhibition	%	0.71
	8102636	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.4	CHEMBL3831	Homo sapiens	Inhibition	%	-1.4
	8102860	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.11	CHEMBL3831	Homo sapiens	Inhibition	%	-0.11
	8103038	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.38	CHEMBL3831	Homo sapiens	Inhibition	%	1.38
	8103234	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.39	CHEMBL3831	Homo sapiens	Inhibition	%	1.39
	8103596	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.24	CHEMBL3831	Homo sapiens	Inhibition	%	-1.24
	8103746	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.04	CHEMBL3831	Homo sapiens	Inhibition	%	1.04
	8103970	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-0.7	CHEMBL3831	Homo sapiens	Inhibition	%	-0.7
	8104155	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.4	CHEMBL3831	Homo sapiens	Inhibition	%	-0.4
	8104303	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.23	CHEMBL3831	Homo sapiens	Inhibition	%	6.23
	8104673	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	16.55	CHEMBL3831	Homo sapiens	Inhibition	%	16.55
	8105011	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-1.45	CHEMBL3831	Homo sapiens	Inhibition	%	-1.45
	8105151	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.75	CHEMBL3831	Homo sapiens	Inhibition	%	0.75
	8105541	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.47	CHEMBL3831	Homo sapiens	Inhibition	%	2.47
	8105679	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	15.6	CHEMBL3831	Homo sapiens	Inhibition	%	15.6
	8105959	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.32	CHEMBL3831	Homo sapiens	Inhibition	%	-0.32
	8106348	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.22	CHEMBL3831	Homo sapiens	Inhibition	%	-0.22
	8106504	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	10.34	CHEMBL3831	Homo sapiens	Inhibition	%	10.34
	8106857	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.33	CHEMBL3831	Homo sapiens	Inhibition	%	0.33
	8107202	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.54	CHEMBL3831	Homo sapiens	Inhibition	%	1.54
	8107374	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.02	CHEMBL3831	Homo sapiens	Inhibition	%	-0.02
	8107575	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	18.13	CHEMBL3831	Homo sapiens	Inhibition	%	18.13
	8107799	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.22	CHEMBL3831	Homo sapiens	Inhibition	%	2.22
	8107934	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	3.47	CHEMBL3831	Homo sapiens	Inhibition	%	3.47
	8108316	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.67	CHEMBL3831	Homo sapiens	Inhibition	%	1.67
	8108491	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.42	CHEMBL3831	Homo sapiens	Inhibition	%	0.42
	8108638	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.52	CHEMBL3831	Homo sapiens	Inhibition	%	3.52
	8108862	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	19.67	CHEMBL3831	Homo sapiens	Inhibition	%	19.67
	8109004	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.42	CHEMBL3831	Homo sapiens	Inhibition	%	-0.42
	8109342	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.21	CHEMBL3831	Homo sapiens	Inhibition	%	1.21
	8109472	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.28	CHEMBL3831	Homo sapiens	Inhibition	%	2.28
	8109696	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.46	CHEMBL3831	Homo sapiens	Inhibition	%	0.46
	8109867	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	9.93	CHEMBL3831	Homo sapiens	Inhibition	%	9.93
	8109999	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-1.15	CHEMBL3831	Homo sapiens	Inhibition	%	-1.15
	8110223	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.52	CHEMBL3831	Homo sapiens	Inhibition	%	2.52
	8110278	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.33	CHEMBL3831	Homo sapiens	Inhibition	%	0.33
	8110502	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.34	CHEMBL3831	Homo sapiens	Inhibition	%	0.34
	8110668	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.71	CHEMBL3831	Homo sapiens	Inhibition	%	2.71
	8110826	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	7.01	CHEMBL3831	Homo sapiens	Inhibition	%	7.01
	8111050	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	10.07	CHEMBL3831	Homo sapiens	Inhibition	%	10.07
	8111173	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.55	CHEMBL3831	Homo sapiens	Inhibition	%	2.55
	8111524	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	12.88	CHEMBL3831	Homo sapiens	Inhibition	%	12.88
	8111690	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.11	CHEMBL3831	Homo sapiens	Inhibition	%	2.11
	8111914	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.29	CHEMBL3831	Homo sapiens	Inhibition	%	3.29
	8112119	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.99	CHEMBL3831	Homo sapiens	Inhibition	%	6.99
	8112256	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.2	CHEMBL3831	Homo sapiens	Inhibition	%	-0.2
	8112648	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	0.24	CHEMBL3831	Homo sapiens	Inhibition	%	0.24
	8112820	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-1.43	CHEMBL3831	Homo sapiens	Inhibition	%	-1.43
	8113196	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.74	CHEMBL3831	Homo sapiens	Inhibition	%	1.74
	8113332	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.35	CHEMBL3831	Homo sapiens	Inhibition	%	3.35
	8113556	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.91	CHEMBL3831	Homo sapiens	Inhibition	%	0.91
	8113680	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.51	CHEMBL3831	Homo sapiens	Inhibition	%	3.51
	8114020	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.87	CHEMBL3831	Homo sapiens	Inhibition	%	1.87
	8114196	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.72	CHEMBL3831	Homo sapiens	Inhibition	%	0.72
	8114552	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.08	CHEMBL3831	Homo sapiens	Inhibition	%	1.08
	8114828	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.99	CHEMBL3831	Homo sapiens	Inhibition	%	0.99
	8114994	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-0.86	CHEMBL3831	Homo sapiens	Inhibition	%	-0.86
	8115383	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.78	CHEMBL3831	Homo sapiens	Inhibition	%	1.78
	8115503	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-0.89	CHEMBL3831	Homo sapiens	Inhibition	%	-0.89
	8115727	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.48	CHEMBL3831	Homo sapiens	Inhibition	%	-0.48
	8115860	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	51.92	CHEMBL3831	Homo sapiens	Inhibition	%	51.92
	8116243	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	32.21	CHEMBL3831	Homo sapiens	Inhibition	%	32.21
	8116446	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	19.27	CHEMBL3831	Homo sapiens	Inhibition	%	19.27
	8116580	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.88	CHEMBL3831	Homo sapiens	Inhibition	%	0.88
	8116804	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.41	CHEMBL3831	Homo sapiens	Inhibition	%	-1.41
	8116976	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.5	CHEMBL3831	Homo sapiens	Inhibition	%	2.5
	8117147	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.18	CHEMBL3831	Homo sapiens	Inhibition	%	-2.18
	8117371	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.98	CHEMBL3831	Homo sapiens	Inhibition	%	0.98
	8117529	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	10.6	CHEMBL3831	Homo sapiens	Inhibition	%	10.6
	8117883	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.76	CHEMBL3831	Homo sapiens	Inhibition	%	3.76
	8118021	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.25	CHEMBL3831	Homo sapiens	Inhibition	%	-0.25
	8118361	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.8	CHEMBL3831	Homo sapiens	Inhibition	%	1.8
	8118533	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.07	CHEMBL3831	Homo sapiens	Inhibition	%	5.07
	8118757	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.88	CHEMBL3831	Homo sapiens	Inhibition	%	1.88
	8118893	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.25	CHEMBL3831	Homo sapiens	Inhibition	%	2.25
	8119164	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-2.0	CHEMBL3831	Homo sapiens	Inhibition	%	-2.0
	8119323	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.65	CHEMBL3831	Homo sapiens	Inhibition	%	2.65
	8119547	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-0.32	CHEMBL3831	Homo sapiens	Inhibition	%	-0.32
	8119714	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.36	CHEMBL3831	Homo sapiens	Inhibition	%	-0.36
	8120057	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.61	CHEMBL3831	Homo sapiens	Inhibition	%	0.61
	8120196	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.06	CHEMBL3831	Homo sapiens	Inhibition	%	-0.06
	8120580	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.65	CHEMBL3831	Homo sapiens	Inhibition	%	-1.65
	8120781	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	62.24	CHEMBL3831	Homo sapiens	Inhibition	%	62.24
	8121133	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.8	CHEMBL3831	Homo sapiens	Inhibition	%	-0.8
	8121305	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.11	CHEMBL3831	Homo sapiens	Inhibition	%	-0.11
	8121696	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.73	CHEMBL3831	Homo sapiens	Inhibition	%	4.73
	8121859	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.95	CHEMBL3831	Homo sapiens	Inhibition	%	1.95
	8122204	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.02	CHEMBL3831	Homo sapiens	Inhibition	%	-0.02
	8122342	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.71	CHEMBL3831	Homo sapiens	Inhibition	%	1.71
	8122566	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.29	CHEMBL3831	Homo sapiens	Inhibition	%	6.29
	8122686	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.57	CHEMBL3831	Homo sapiens	Inhibition	%	1.57
	8123077	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.61	CHEMBL3831	Homo sapiens	Inhibition	%	4.61
	8123219	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.29	CHEMBL3831	Homo sapiens	Inhibition	%	2.29
	8123497	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.1	CHEMBL3831	Homo sapiens	Inhibition	%	-0.1
	8123871	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	6.47	CHEMBL3831	Homo sapiens	Inhibition	%	6.47
	8124038	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.99	CHEMBL3831	Homo sapiens	Inhibition	%	0.99
	8124381	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	1.23	CHEMBL3831	Homo sapiens	Inhibition	%	1.23
	8124520	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.02	CHEMBL3831	Homo sapiens	Inhibition	%	2.02
	8124744	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-1.88	CHEMBL3831	Homo sapiens	Inhibition	%	-1.88
	8124909	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.58	CHEMBL3831	Homo sapiens	Inhibition	%	1.58
	8125110	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.93	CHEMBL3831	Homo sapiens	Inhibition	%	1.93
	8125464	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.83	CHEMBL3831	Homo sapiens	Inhibition	%	0.83
	8125632	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.4	CHEMBL3831	Homo sapiens	Inhibition	%	0.4
	8125856	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.47	CHEMBL3831	Homo sapiens	Inhibition	%	0.47
	8126020	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-2.48	CHEMBL3831	Homo sapiens	Inhibition	%	-2.48
	8126184	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.32	CHEMBL3831	Homo sapiens	Inhibition	%	6.32
	8126408	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.28	CHEMBL3831	Homo sapiens	Inhibition	%	3.28
	8126523	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.89	CHEMBL3831	Homo sapiens	Inhibition	%	0.89
	8126883	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	34.58	CHEMBL3831	Homo sapiens	Inhibition	%	34.58
	8127005	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.71	CHEMBL3831	Homo sapiens	Inhibition	%	2.71
	8127229	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.07	CHEMBL3831	Homo sapiens	Inhibition	%	4.07
	8127396	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.49	CHEMBL3831	Homo sapiens	Inhibition	%	2.49
	8127538	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	12.25	CHEMBL3831	Homo sapiens	Inhibition	%	12.25
	8127762	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.27	CHEMBL3831	Homo sapiens	Inhibition	%	1.27
	8127826	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.41	CHEMBL3831	Homo sapiens	Inhibition	%	0.41
	8128050	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	5.64	CHEMBL3831	Homo sapiens	Inhibition	%	5.64
	8128202	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-1.4	CHEMBL3831	Homo sapiens	Inhibition	%	-1.4
	8128369	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	4.05	CHEMBL3831	Homo sapiens	Inhibition	%	4.05
	8128593	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.5	CHEMBL3831	Homo sapiens	Inhibition	%	1.5
	8128712	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	21.36	CHEMBL3831	Homo sapiens	Inhibition	%	21.36
	8129073	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	6.07	CHEMBL3831	Homo sapiens	Inhibition	%	6.07
	8129244	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.72	CHEMBL3831	Homo sapiens	Inhibition	%	-1.72
	8129433	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.62	CHEMBL3831	Homo sapiens	Inhibition	%	4.62
	8129657	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.98	CHEMBL3831	Homo sapiens	Inhibition	%	0.98
	8129796	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.5	CHEMBL3831	Homo sapiens	Inhibition	%	1.5
	8130181	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.13	CHEMBL3831	Homo sapiens	Inhibition	%	2.13
	8130353	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.95	CHEMBL3831	Homo sapiens	Inhibition	%	1.95
	8130737	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	16.16	CHEMBL3831	Homo sapiens	Inhibition	%	16.16
	8130853	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-2.4	CHEMBL3831	Homo sapiens	Inhibition	%	-2.4
	8131216	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.73	CHEMBL3831	Homo sapiens	Inhibition	%	1.73
	8131560	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.92	CHEMBL3831	Homo sapiens	Inhibition	%	1.92
	8131727	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.64	CHEMBL3831	Homo sapiens	Inhibition	%	2.64
	8132092	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.83	CHEMBL3831	Homo sapiens	Inhibition	%	3.83
	8132378	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.4	CHEMBL3831	Homo sapiens	Inhibition	%	0.4
	8132525	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.77	CHEMBL3831	Homo sapiens	Inhibition	%	1.77
	8132917	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.58	CHEMBL3831	Homo sapiens	Inhibition	%	0.58
	8133038	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.61	CHEMBL3831	Homo sapiens	Inhibition	%	-0.61
	8133262	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.93	CHEMBL3831	Homo sapiens	Inhibition	%	2.93
	8133400	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-2.03	CHEMBL3831	Homo sapiens	Inhibition	%	-2.03
	8133572	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.33	CHEMBL3831	Homo sapiens	Inhibition	%	0.33
	8133796	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.36	CHEMBL3831	Homo sapiens	Inhibition	%	-0.36
	8133976	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	8.38	CHEMBL3831	Homo sapiens	Inhibition	%	8.38
	8134124	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.22	CHEMBL3831	Homo sapiens	Inhibition	%	-0.22
	8134348	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	3.33	CHEMBL3831	Homo sapiens	Inhibition	%	3.33
	8134508	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.93	CHEMBL3831	Homo sapiens	Inhibition	%	-0.93
	8134692	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.67	CHEMBL3831	Homo sapiens	Inhibition	%	2.67
	8135076	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.02	CHEMBL3831	Homo sapiens	Inhibition	%	1.02
	8135191	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-1.37	CHEMBL3831	Homo sapiens	Inhibition	%	-1.37
	8135415	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.21	CHEMBL3831	Homo sapiens	Inhibition	%	0.21
	8135556	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.49	CHEMBL3831	Homo sapiens	Inhibition	%	4.49
	8135901	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.71	CHEMBL3831	Homo sapiens	Inhibition	%	1.71
	8136069	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-5.9	CHEMBL3831	Homo sapiens	Inhibition	%	-5.9
	8136437	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.67	CHEMBL3831	Homo sapiens	Inhibition	%	0.67
	8136727	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.79	CHEMBL3831	Homo sapiens	Inhibition	%	1.79
	8136862	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.78	CHEMBL3831	Homo sapiens	Inhibition	%	-0.78
	8137086	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.36	CHEMBL3831	Homo sapiens	Inhibition	%	3.36
	8137249	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.04	CHEMBL3831	Homo sapiens	Inhibition	%	0.04
	8137593	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.03	CHEMBL3831	Homo sapiens	Inhibition	%	0.03
	8137741	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.15	CHEMBL3831	Homo sapiens	Inhibition	%	1.15
	8138131	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.45	CHEMBL3831	Homo sapiens	Inhibition	%	3.45
	8138310	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.22	CHEMBL3831	Homo sapiens	Inhibition	%	0.22
	8138682	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.38	CHEMBL3831	Homo sapiens	Inhibition	%	0.38
	8138840	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.97	CHEMBL3831	Homo sapiens	Inhibition	%	-0.97
	8139025	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	15.6	CHEMBL3831	Homo sapiens	Inhibition	%	15.6
	8139249	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.39	CHEMBL3831	Homo sapiens	Inhibition	%	-0.39
	8139408	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.96	CHEMBL3831	Homo sapiens	Inhibition	%	4.96
	8139746	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.46	CHEMBL3831	Homo sapiens	Inhibition	%	1.46
	8139887	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.19	CHEMBL3831	Homo sapiens	Inhibition	%	2.19
	8140111	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.61	CHEMBL3831	Homo sapiens	Inhibition	%	2.61
	8140234	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.25	CHEMBL3831	Homo sapiens	Inhibition	%	2.25
	8140393	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.57	CHEMBL3831	Homo sapiens	Inhibition	%	0.57
	8140617	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.35	CHEMBL3831	Homo sapiens	Inhibition	%	2.35
	8140760	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.68	CHEMBL3831	Homo sapiens	Inhibition	%	2.68
	8141062	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.14	CHEMBL3831	Homo sapiens	Inhibition	%	1.14
	8141416	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.19	CHEMBL3831	Homo sapiens	Inhibition	%	0.19
	8141576	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	4.97	CHEMBL3831	Homo sapiens	Inhibition	%	4.97
	8141919	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.9	CHEMBL3831	Homo sapiens	Inhibition	%	0.9
	8142080	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.35	CHEMBL3831	Homo sapiens	Inhibition	%	-1.35
	8142304	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.07	CHEMBL3831	Homo sapiens	Inhibition	%	-0.07
	8142472	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	8.53	CHEMBL3831	Homo sapiens	Inhibition	%	8.53
	8142648	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.07	CHEMBL3831	Homo sapiens	Inhibition	%	1.07
	8143021	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.12	CHEMBL3831	Homo sapiens	Inhibition	%	2.12
	8143176	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-0.22	CHEMBL3831	Homo sapiens	Inhibition	%	-0.22
	8143400	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.46	CHEMBL3831	Homo sapiens	Inhibition	%	0.46
	8143587	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.16	CHEMBL3831	Homo sapiens	Inhibition	%	2.16
	8143746	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.89	CHEMBL3831	Homo sapiens	Inhibition	%	1.89
	8144084	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.23	CHEMBL3831	Homo sapiens	Inhibition	%	0.23
	8144447	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-3.0	CHEMBL3831	Homo sapiens	Inhibition	%	-3.0
	8144577	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.16	CHEMBL3831	Homo sapiens	Inhibition	%	4.16
	8144954	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.52	CHEMBL3831	Homo sapiens	Inhibition	%	1.52
	8145091	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.66	CHEMBL3831	Homo sapiens	Inhibition	%	0.66
	8145315	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-0.14	CHEMBL3831	Homo sapiens	Inhibition	%	-0.14
	8145404	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.39	CHEMBL3831	Homo sapiens	Inhibition	%	0.39
	8145752	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.11	CHEMBL3831	Homo sapiens	Inhibition	%	0.11
	8145913	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-0.82	CHEMBL3831	Homo sapiens	Inhibition	%	-0.82
	8146137	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.99	CHEMBL3831	Homo sapiens	Inhibition	%	2.99
	8146257	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.92	CHEMBL3831	Homo sapiens	Inhibition	%	0.92
	8146641	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.05	CHEMBL3831	Homo sapiens	Inhibition	%	2.05
	8146808	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	43.4	CHEMBL3831	Homo sapiens	Inhibition	%	43.4
	8146977	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-2.51	CHEMBL3831	Homo sapiens	Inhibition	%	-2.51
	8147201	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.48	CHEMBL3831	Homo sapiens	Inhibition	%	-0.48
	8147343	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.36	CHEMBL3831	Homo sapiens	Inhibition	%	-0.36
	8147720	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.74	CHEMBL3831	Homo sapiens	Inhibition	%	-0.74
	8147907	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.84	CHEMBL3831	Homo sapiens	Inhibition	%	0.84
	8148065	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.11	CHEMBL3831	Homo sapiens	Inhibition	%	4.11
	8148289	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.14	CHEMBL3831	Homo sapiens	Inhibition	%	0.14
	8148403	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.56	CHEMBL3831	Homo sapiens	Inhibition	%	-0.56
	8148766	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.66	CHEMBL3831	Homo sapiens	Inhibition	%	0.66
	8148904	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.73	CHEMBL3831	Homo sapiens	Inhibition	%	2.73
	8149128	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.02	CHEMBL3831	Homo sapiens	Inhibition	%	4.02
	8149287	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.92	CHEMBL3831	Homo sapiens	Inhibition	%	-0.92
	8149645	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-0.85	CHEMBL3831	Homo sapiens	Inhibition	%	-0.85
	8149743	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-0.87	CHEMBL3831	Homo sapiens	Inhibition	%	-0.87
	8149967	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.31	CHEMBL3831	Homo sapiens	Inhibition	%	0.31
	8150092	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.8	CHEMBL3831	Homo sapiens	Inhibition	%	-0.8
	8150476	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-2.05	CHEMBL3831	Homo sapiens	Inhibition	%	-2.05
	8150596	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.67	CHEMBL3831	Homo sapiens	Inhibition	%	-0.67
	8150985	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	5.44	CHEMBL3831	Homo sapiens	Inhibition	%	5.44
	8151148	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	2.15	CHEMBL3831	Homo sapiens	Inhibition	%	2.15
	8151549	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.31	CHEMBL3831	Homo sapiens	Inhibition	%	1.31
	8151687	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.61	CHEMBL3831	Homo sapiens	Inhibition	%	0.61
	8152065	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.37	CHEMBL3831	Homo sapiens	Inhibition	%	1.37
	8152253	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.91	CHEMBL3831	Homo sapiens	Inhibition	%	4.91
	8152635	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.64	CHEMBL3831	Homo sapiens	Inhibition	%	2.64
	8152749	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.55	CHEMBL3831	Homo sapiens	Inhibition	%	0.55
	8152973	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.54	CHEMBL3831	Homo sapiens	Inhibition	%	3.54
	8153112	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.8	CHEMBL3831	Homo sapiens	Inhibition	%	0.8
	8153473	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.18	CHEMBL3831	Homo sapiens	Inhibition	%	2.18
	8153630	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.1	CHEMBL3831	Homo sapiens	Inhibition	%	-1.1
	8153987	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	14.01	CHEMBL3831	Homo sapiens	Inhibition	%	14.01
	8154308	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.05	CHEMBL3831	Homo sapiens	Inhibition	%	-0.05
	8154434	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.83	CHEMBL3831	Homo sapiens	Inhibition	%	0.83
	8154817	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-2.06	CHEMBL3831	Homo sapiens	Inhibition	%	-2.06
	8154937	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.79	CHEMBL3831	Homo sapiens	Inhibition	%	-0.79
	8155161	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.52	CHEMBL3831	Homo sapiens	Inhibition	%	-0.52
	8155337	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-2.12	CHEMBL3831	Homo sapiens	Inhibition	%	-2.12
	8155498	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	5.77	CHEMBL3831	Homo sapiens	Inhibition	%	5.77
	8155722	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.26	CHEMBL3831	Homo sapiens	Inhibition	%	0.26
	8155900	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.56	CHEMBL3831	Homo sapiens	Inhibition	%	1.56
	8156038	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.02	CHEMBL3831	Homo sapiens	Inhibition	%	0.02
	8156262	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.82	CHEMBL3831	Homo sapiens	Inhibition	%	0.82
	8156474	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.3	CHEMBL3831	Homo sapiens	Inhibition	%	1.3
	8156624	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-4.12	CHEMBL3831	Homo sapiens	Inhibition	%	-4.12
	8156848	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.88	CHEMBL3831	Homo sapiens	Inhibition	%	0.88
	8156991	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.59	CHEMBL3831	Homo sapiens	Inhibition	%	7.59
	8157335	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.76	CHEMBL3831	Homo sapiens	Inhibition	%	4.76
	8157476	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.26	CHEMBL3831	Homo sapiens	Inhibition	%	0.26
	8157830	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-0.33	CHEMBL3831	Homo sapiens	Inhibition	%	-0.33
	8157991	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.13	CHEMBL3831	Homo sapiens	Inhibition	%	3.13
	8158215	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.44	CHEMBL3831	Homo sapiens	Inhibition	%	-0.44
	8158241	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.75	CHEMBL3831	Homo sapiens	Inhibition	%	1.75
	8158465	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.6	CHEMBL3831	Homo sapiens	Inhibition	%	1.6
	8158623	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.34	CHEMBL3831	Homo sapiens	Inhibition	%	6.34
	8158792	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-1.51	CHEMBL3831	Homo sapiens	Inhibition	%	-1.51
	8159016	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.47	CHEMBL3831	Homo sapiens	Inhibition	%	-0.47
	8159151	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.4	CHEMBL3831	Homo sapiens	Inhibition	%	6.4
	8159495	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.04	CHEMBL3831	Homo sapiens	Inhibition	%	1.04
	8159626	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.24	CHEMBL3831	Homo sapiens	Inhibition	%	6.24
	8159850	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	6.68	CHEMBL3831	Homo sapiens	Inhibition	%	6.68
	8159991	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.22	CHEMBL3831	Homo sapiens	Inhibition	%	1.22
	8160352	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.25	CHEMBL3831	Homo sapiens	Inhibition	%	1.25
	8160502	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.84	CHEMBL3831	Homo sapiens	Inhibition	%	1.84
	8160796	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.45	CHEMBL3831	Homo sapiens	Inhibition	%	3.45
	8161170	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.47	CHEMBL3831	Homo sapiens	Inhibition	%	2.47
	8161313	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	0.05	CHEMBL3831	Homo sapiens	Inhibition	%	0.05
	8161662	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.47	CHEMBL3831	Homo sapiens	Inhibition	%	1.47
	8161800	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.54	CHEMBL3831	Homo sapiens	Inhibition	%	3.54
	8162024	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.43	CHEMBL3831	Homo sapiens	Inhibition	%	1.43
	8162154	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	13.28	CHEMBL3831	Homo sapiens	Inhibition	%	13.28
	8162538	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.75	CHEMBL3831	Homo sapiens	Inhibition	%	2.75
	8162791	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	7.14	CHEMBL3831	Homo sapiens	Inhibition	%	7.14
	8162939	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	14.04	CHEMBL3831	Homo sapiens	Inhibition	%	14.04
	8163332	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.64	CHEMBL3831	Homo sapiens	Inhibition	%	0.64
	8163466	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-1.51	CHEMBL3831	Homo sapiens	Inhibition	%	-1.51
	8163690	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.57	CHEMBL3831	Homo sapiens	Inhibition	%	2.57
	8163813	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.79	CHEMBL3831	Homo sapiens	Inhibition	%	1.79
	8164171	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	39.95	CHEMBL3831	Homo sapiens	Inhibition	%	39.95
	8164311	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.16	CHEMBL3831	Homo sapiens	Inhibition	%	0.16
	8164690	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	1.3	CHEMBL3831	Homo sapiens	Inhibition	%	1.3
	8164834	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.02	CHEMBL3831	Homo sapiens	Inhibition	%	2.02
	8165128	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.14	CHEMBL3831	Homo sapiens	Inhibition	%	2.14
	8165493	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.74	CHEMBL3831	Homo sapiens	Inhibition	%	-0.74
	8165636	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	14.28	CHEMBL3831	Homo sapiens	Inhibition	%	14.28
	8165860	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-1.98	CHEMBL3831	Homo sapiens	Inhibition	%	-1.98
	8165986	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	8.31	CHEMBL3831	Homo sapiens	Inhibition	%	8.31
	8166348	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.04	CHEMBL3831	Homo sapiens	Inhibition	%	9.04
	8166478	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-0.88	CHEMBL3831	Homo sapiens	Inhibition	%	-0.88
	8166803	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	8.17	CHEMBL3831	Homo sapiens	Inhibition	%	8.17
	8167115	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.17	CHEMBL3831	Homo sapiens	Inhibition	%	1.17
	8167256	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	46.22	CHEMBL3831	Homo sapiens	Inhibition	%	46.22
	8167480	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.24	CHEMBL3831	Homo sapiens	Inhibition	%	1.24
	8167644	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.22	CHEMBL3831	Homo sapiens	Inhibition	%	1.22
	8168001	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-0.64	CHEMBL3831	Homo sapiens	Inhibition	%	-0.64
	8168125	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.93	CHEMBL3831	Homo sapiens	Inhibition	%	-0.93
	8168490	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.93	CHEMBL3831	Homo sapiens	Inhibition	%	1.93
	8168626	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.44	CHEMBL3831	Homo sapiens	Inhibition	%	0.44
	8168850	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.51	CHEMBL3831	Homo sapiens	Inhibition	%	0.51
	8169014	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	9.5	CHEMBL3831	Homo sapiens	Inhibition	%	9.5
	8169156	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.79	CHEMBL3831	Homo sapiens	Inhibition	%	-0.79
	8169380	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.66	CHEMBL3831	Homo sapiens	Inhibition	%	0.66
	8169460	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.82	CHEMBL3831	Homo sapiens	Inhibition	%	4.82
	8169684	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	7.88	CHEMBL3831	Homo sapiens	Inhibition	%	7.88
	8169818	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.24	CHEMBL3831	Homo sapiens	Inhibition	%	0.24
	8170187	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.58	CHEMBL3831	Homo sapiens	Inhibition	%	0.58
	8170312	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.47	CHEMBL3831	Homo sapiens	Inhibition	%	0.47
	8170676	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	11.3	CHEMBL3831	Homo sapiens	Inhibition	%	11.3
	8170811	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.43	CHEMBL3831	Homo sapiens	Inhibition	%	0.43
	8171035	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-1.19	CHEMBL3831	Homo sapiens	Inhibition	%	-1.19
	8171232	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.57	CHEMBL3831	Homo sapiens	Inhibition	%	1.57
	8171449	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	10.97	CHEMBL3831	Homo sapiens	Inhibition	%	10.97
	8171814	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	9.0	CHEMBL3831	Homo sapiens	Inhibition	%	9.0
	8171967	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.05	CHEMBL3831	Homo sapiens	Inhibition	%	0.05
	8172323	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.32	CHEMBL3831	Homo sapiens	Inhibition	%	3.32
	8172451	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.63	CHEMBL3831	Homo sapiens	Inhibition	%	3.63
	8172675	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.46	CHEMBL3831	Homo sapiens	Inhibition	%	-0.46
	8172817	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.98	CHEMBL3831	Homo sapiens	Inhibition	%	1.98
	8173177	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	4.42	CHEMBL3831	Homo sapiens	Inhibition	%	4.42
	8173342	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.24	CHEMBL3831	Homo sapiens	Inhibition	%	1.24
	8173707	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.17	CHEMBL3831	Homo sapiens	Inhibition	%	1.17
	8174018	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	40.41	CHEMBL3831	Homo sapiens	Inhibition	%	40.41
	8174150	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.36	CHEMBL3831	Homo sapiens	Inhibition	%	0.36
	8174522	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.08	CHEMBL3831	Homo sapiens	Inhibition	%	0.08
	8174644	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.34	CHEMBL3831	Homo sapiens	Inhibition	%	1.34
	8174868	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-0.45	CHEMBL3831	Homo sapiens	Inhibition	%	-0.45
	8175011	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	46.49	CHEMBL3831	Homo sapiens	Inhibition	%	46.49
	8175371	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.01	CHEMBL3831	Homo sapiens	Inhibition	%	1.01
	8175627	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	10.16	CHEMBL3831	Homo sapiens	Inhibition	%	10.16
	8175790	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-0.09	CHEMBL3831	Homo sapiens	Inhibition	%	-0.09
	8176167	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.09	CHEMBL3831	Homo sapiens	Inhibition	%	4.09
	8176316	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.5	CHEMBL3831	Homo sapiens	Inhibition	%	2.5
	8176540	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.86	CHEMBL3831	Homo sapiens	Inhibition	%	3.86
	8176672	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	13.43	CHEMBL3831	Homo sapiens	Inhibition	%	13.43
	8177026	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.66	CHEMBL3831	Homo sapiens	Inhibition	%	-0.66
	8177168	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	0.37	CHEMBL3831	Homo sapiens	Inhibition	%	0.37
	8177530	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	1.57	CHEMBL3831	Homo sapiens	Inhibition	%	1.57
	8177694	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.54	CHEMBL3831	Homo sapiens	Inhibition	%	2.54
	8177918	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.92	CHEMBL3831	Homo sapiens	Inhibition	%	0.92
	8178058	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.11	CHEMBL3831	Homo sapiens	Inhibition	%	5.11
	8178370	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.94	CHEMBL3831	Homo sapiens	Inhibition	%	0.94
	8178497	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-0.07	CHEMBL3831	Homo sapiens	Inhibition	%	-0.07
	8178721	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.91	CHEMBL3831	Homo sapiens	Inhibition	%	1.91
	8178870	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.08	CHEMBL3831	Homo sapiens	Inhibition	%	1.08
	8179217	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.03	CHEMBL3831	Homo sapiens	Inhibition	%	2.03
	8179361	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	0.88	CHEMBL3831	Homo sapiens	Inhibition	%	0.88
	8179585	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	21.34	CHEMBL3831	Homo sapiens	Inhibition	%	21.34
	8179722	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.65	CHEMBL3831	Homo sapiens	Inhibition	%	-0.65
	8179979	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.18	CHEMBL3831	Homo sapiens	Inhibition	%	1.18
	8180133	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.25	CHEMBL3831	Homo sapiens	Inhibition	%	1.25
	8180357	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.15	CHEMBL3831	Homo sapiens	Inhibition	%	-1.15
	8180513	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	23.38	CHEMBL3831	Homo sapiens	Inhibition	%	23.38
	8180885	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	18.57	CHEMBL3831	Homo sapiens	Inhibition	%	18.57
	8181018	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.65	CHEMBL3831	Homo sapiens	Inhibition	%	2.65
	8181373	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.01	CHEMBL3831	Homo sapiens	Inhibition	%	2.01
	8181513	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.29	CHEMBL3831	Homo sapiens	Inhibition	%	3.29
	8181737	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.54	CHEMBL3831	Homo sapiens	Inhibition	%	1.54
	8181876	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	11.81	CHEMBL3831	Homo sapiens	Inhibition	%	11.81
	8182263	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	0.96	CHEMBL3831	Homo sapiens	Inhibition	%	0.96
	8182403	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.1	CHEMBL3831	Homo sapiens	Inhibition	%	-0.1
	8182719	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.09	CHEMBL3831	Homo sapiens	Inhibition	%	1.09
	8183065	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.76	CHEMBL3831	Homo sapiens	Inhibition	%	1.76
	8183214	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.52	CHEMBL3831	Homo sapiens	Inhibition	%	-0.52
	8183567	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.43	CHEMBL3831	Homo sapiens	Inhibition	%	6.43
	8183933	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.41	CHEMBL3831	Homo sapiens	Inhibition	%	0.41
	8184069	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.2	CHEMBL3831	Homo sapiens	Inhibition	%	-0.2
	8184335	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.72	CHEMBL3831	Homo sapiens	Inhibition	%	0.72
	8184706	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.66	CHEMBL3831	Homo sapiens	Inhibition	%	2.66
	8184863	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-1.3	CHEMBL3831	Homo sapiens	Inhibition	%	-1.3
	8185236	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.37	CHEMBL3831	Homo sapiens	Inhibition	%	0.37
	8185367	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.93	CHEMBL3831	Homo sapiens	Inhibition	%	1.93
	8185591	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.67	CHEMBL3831	Homo sapiens	Inhibition	%	1.67
	8185722	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	18.6	CHEMBL3831	Homo sapiens	Inhibition	%	18.6
	8186085	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.6	CHEMBL3831	Homo sapiens	Inhibition	%	3.6
	8186226	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.52	CHEMBL3831	Homo sapiens	Inhibition	%	0.52
	8186450	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.59	CHEMBL3831	Homo sapiens	Inhibition	%	0.59
	8186614	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-0.02	CHEMBL3831	Homo sapiens	Inhibition	%	-0.02
	8186753	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.64	CHEMBL3831	Homo sapiens	Inhibition	%	2.64
	8186977	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.5	CHEMBL3831	Homo sapiens	Inhibition	%	2.5
	8187075	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.97	CHEMBL3831	Homo sapiens	Inhibition	%	0.97
	8187423	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-0.54	CHEMBL3831	Homo sapiens	Inhibition	%	-0.54
	8187571	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.4	CHEMBL3831	Homo sapiens	Inhibition	%	1.4
	8187795	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.01	CHEMBL3831	Homo sapiens	Inhibition	%	-0.01
	8187924	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.45	CHEMBL3831	Homo sapiens	Inhibition	%	4.45
	8188291	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.16	CHEMBL3831	Homo sapiens	Inhibition	%	6.16
	8188426	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.16	CHEMBL3831	Homo sapiens	Inhibition	%	0.16
	8188650	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	3.41	CHEMBL3831	Homo sapiens	Inhibition	%	3.41
	8188700	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.26	CHEMBL3831	Homo sapiens	Inhibition	%	0.26
	8188924	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-1.69	CHEMBL3831	Homo sapiens	Inhibition	%	-1.69
	8189072	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.89	CHEMBL3831	Homo sapiens	Inhibition	%	-0.89
	8189228	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-1.26	CHEMBL3831	Homo sapiens	Inhibition	%	-1.26
	8189452	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.99	CHEMBL3831	Homo sapiens	Inhibition	%	2.99
	8189601	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.33	CHEMBL3831	Homo sapiens	Inhibition	%	1.33
	8189957	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.74	CHEMBL3831	Homo sapiens	Inhibition	%	2.74
	8190089	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-0.96	CHEMBL3831	Homo sapiens	Inhibition	%	-0.96
	8190313	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.22	CHEMBL3831	Homo sapiens	Inhibition	%	2.22
	8190453	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.08	CHEMBL3831	Homo sapiens	Inhibition	%	2.08
	8190814	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-0.26	CHEMBL3831	Homo sapiens	Inhibition	%	-0.26
	8190978	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.74	CHEMBL3831	Homo sapiens	Inhibition	%	1.74
	8191340	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	7.11	CHEMBL3831	Homo sapiens	Inhibition	%	7.11
	8191436	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.96	CHEMBL3831	Homo sapiens	Inhibition	%	1.96
	8191660	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-1.01	CHEMBL3831	Homo sapiens	Inhibition	%	-1.01
	8191782	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.62	CHEMBL3831	Homo sapiens	Inhibition	%	2.62
	8192155	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.59	CHEMBL3831	Homo sapiens	Inhibition	%	1.59
	8192284	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.99	CHEMBL3831	Homo sapiens	Inhibition	%	1.99
	8192508	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.82	CHEMBL3831	Homo sapiens	Inhibition	%	0.82
	8192652	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.19	CHEMBL3831	Homo sapiens	Inhibition	%	1.19
	8193012	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.85	CHEMBL3831	Homo sapiens	Inhibition	%	0.85
	8193284	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.15	CHEMBL3831	Homo sapiens	Inhibition	%	0.15
	8193429	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.32	CHEMBL3831	Homo sapiens	Inhibition	%	1.32
	8193810	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	12.55	CHEMBL3831	Homo sapiens	Inhibition	%	12.55
	8193959	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.95	CHEMBL3831	Homo sapiens	Inhibition	%	2.95
	8194183	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.46	CHEMBL3831	Homo sapiens	Inhibition	%	3.46
	8194314	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.85	CHEMBL3831	Homo sapiens	Inhibition	%	2.85
	8194669	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.05	CHEMBL3831	Homo sapiens	Inhibition	%	0.05
	8194812	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.3	CHEMBL3831	Homo sapiens	Inhibition	%	4.3
	8195169	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-0.08	CHEMBL3831	Homo sapiens	Inhibition	%	-0.08
	8195333	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.14	CHEMBL3831	Homo sapiens	Inhibition	%	2.14
	8195557	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	8.29	CHEMBL3831	Homo sapiens	Inhibition	%	8.29
	8195696	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.8	CHEMBL3831	Homo sapiens	Inhibition	%	1.8
	8196018	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.79	CHEMBL3831	Homo sapiens	Inhibition	%	2.79
	8196135	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.28	CHEMBL3831	Homo sapiens	Inhibition	%	0.28
	8196359	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.19	CHEMBL3831	Homo sapiens	Inhibition	%	2.19
	8196509	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.87	CHEMBL3831	Homo sapiens	Inhibition	%	0.87
	8196861	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.68	CHEMBL3831	Homo sapiens	Inhibition	%	1.68
	8197002	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.45	CHEMBL3831	Homo sapiens	Inhibition	%	0.45
	8197363	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.23	CHEMBL3831	Homo sapiens	Inhibition	%	1.23
	8197638	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-0.63	CHEMBL3831	Homo sapiens	Inhibition	%	-0.63
	8197778	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.69	CHEMBL3831	Homo sapiens	Inhibition	%	0.69
	8198002	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	6.01	CHEMBL3831	Homo sapiens	Inhibition	%	6.01
	8198159	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.46	CHEMBL3831	Homo sapiens	Inhibition	%	0.46
	8198521	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-3.26	CHEMBL3831	Homo sapiens	Inhibition	%	-3.26
	8198651	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	0.64	CHEMBL3831	Homo sapiens	Inhibition	%	0.64
	8199006	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.02	CHEMBL3831	Homo sapiens	Inhibition	%	2.02
	8199154	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	0.6	CHEMBL3831	Homo sapiens	Inhibition	%	0.6
	8199378	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.13	CHEMBL3831	Homo sapiens	Inhibition	%	1.13
	8199512	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.96	CHEMBL3831	Homo sapiens	Inhibition	%	0.96
	8199899	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.13	CHEMBL3831	Homo sapiens	Inhibition	%	0.13
	8200037	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.05	CHEMBL3831	Homo sapiens	Inhibition	%	2.05
	8200365	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.74	CHEMBL3831	Homo sapiens	Inhibition	%	0.74
	8200704	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.08	CHEMBL3831	Homo sapiens	Inhibition	%	4.08
	8200854	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.15	CHEMBL3831	Homo sapiens	Inhibition	%	1.15
	8201208	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.32	CHEMBL3831	Homo sapiens	Inhibition	%	2.32
	8201343	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-2.14	CHEMBL3831	Homo sapiens	Inhibition	%	-2.14
	8201567	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.56	CHEMBL3831	Homo sapiens	Inhibition	%	-0.56
	8201700	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.24	CHEMBL3831	Homo sapiens	Inhibition	%	-1.24
	8201979	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.7	CHEMBL3831	Homo sapiens	Inhibition	%	2.7
	8202343	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	Inhibition	%	0.0
	8202510	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.88	CHEMBL3831	Homo sapiens	Inhibition	%	1.88
	8202859	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-2.56	CHEMBL3831	Homo sapiens	Inhibition	%	-2.56
	8202989	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.17	CHEMBL3831	Homo sapiens	Inhibition	%	0.17
	8203213	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.58	CHEMBL3831	Homo sapiens	Inhibition	%	3.58
	8203344	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.14	CHEMBL3831	Homo sapiens	Inhibition	%	1.14
	8203714	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-1.43	CHEMBL3831	Homo sapiens	Inhibition	%	-1.43
	8203848	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.05	CHEMBL3831	Homo sapiens	Inhibition	%	1.05
	8204238	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.18	CHEMBL3831	Homo sapiens	Inhibition	%	1.18
	8204375	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.54	CHEMBL3831	Homo sapiens	Inhibition	%	0.54
	8204599	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.34	CHEMBL3831	Homo sapiens	Inhibition	%	4.34
	8204704	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.63	CHEMBL3831	Homo sapiens	Inhibition	%	0.63
	8205043	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	17.52	CHEMBL3831	Homo sapiens	Inhibition	%	17.52
	8205192	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.85	CHEMBL3831	Homo sapiens	Inhibition	%	0.85
	8205416	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.93	CHEMBL3831	Homo sapiens	Inhibition	%	7.93
	8205552	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.34	CHEMBL3831	Homo sapiens	Inhibition	%	1.34
	8205915	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-1.05	CHEMBL3831	Homo sapiens	Inhibition	%	-1.05
	8206047	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.74	CHEMBL3831	Homo sapiens	Inhibition	%	-1.74
	8206271	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.07	CHEMBL3831	Homo sapiens	Inhibition	%	0.07
	8206323	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.27	CHEMBL3831	Homo sapiens	Inhibition	%	-0.27
	8206547	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.6	CHEMBL3831	Homo sapiens	Inhibition	%	1.6
	8206690	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.67	CHEMBL3831	Homo sapiens	Inhibition	%	0.67
	8206870	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.6	CHEMBL3831	Homo sapiens	Inhibition	%	1.6
	8207094	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.24	CHEMBL3831	Homo sapiens	Inhibition	%	2.24
	8207220	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.01	CHEMBL3831	Homo sapiens	Inhibition	%	1.01
	8207574	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	-0.95	CHEMBL3831	Homo sapiens	Inhibition	%	-0.95
	8207706	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.84	CHEMBL3831	Homo sapiens	Inhibition	%	4.84
	8208075	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-1.01	CHEMBL3831	Homo sapiens	Inhibition	%	-1.01
	8208207	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.97	CHEMBL3831	Homo sapiens	Inhibition	%	2.97
	8208431	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.63	CHEMBL3831	Homo sapiens	Inhibition	%	1.63
	8208597	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	-0.71	CHEMBL3831	Homo sapiens	Inhibition	%	-0.71
	8208954	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.55	CHEMBL3831	Homo sapiens	Inhibition	%	3.55
	8209059	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-5.23	CHEMBL3831	Homo sapiens	Inhibition	%	-5.23
	8209283	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.68	CHEMBL3831	Homo sapiens	Inhibition	%	0.68
	8209399	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-3.64	CHEMBL3831	Homo sapiens	Inhibition	%	-3.64
	8209773	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.75	CHEMBL3831	Homo sapiens	Inhibition	%	0.75
	8209909	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.46	CHEMBL3831	Homo sapiens	Inhibition	%	1.46
	8210133	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.26	CHEMBL3831	Homo sapiens	Inhibition	%	2.26
	8210274	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.03	CHEMBL3831	Homo sapiens	Inhibition	%	0.03
	8210634	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.15	CHEMBL3831	Homo sapiens	Inhibition	%	0.15
	8210893	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.93	CHEMBL3831	Homo sapiens	Inhibition	%	2.93
	8211037	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-1.89	CHEMBL3831	Homo sapiens	Inhibition	%	-1.89
	8211431	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.88	CHEMBL3831	Homo sapiens	Inhibition	%	0.88
	8211554	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-0.63	CHEMBL3831	Homo sapiens	Inhibition	%	-0.63
	8211907	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.24	CHEMBL3831	Homo sapiens	Inhibition	%	5.24
	8212039	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.3	CHEMBL3831	Homo sapiens	Inhibition	%	3.3
	8212263	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.78	CHEMBL3831	Homo sapiens	Inhibition	%	4.78
	8212404	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.15	CHEMBL3831	Homo sapiens	Inhibition	%	1.15
	8212761	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	0.64	CHEMBL3831	Homo sapiens	Inhibition	%	0.64
	8212931	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.34	CHEMBL3831	Homo sapiens	Inhibition	%	0.34
	8213284	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	17.87	CHEMBL3831	Homo sapiens	Inhibition	%	17.87
	8213612	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.46	CHEMBL3831	Homo sapiens	Inhibition	%	-0.46
	8213725	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.77	CHEMBL3831	Homo sapiens	Inhibition	%	1.77
	8213949	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.34	CHEMBL3831	Homo sapiens	Inhibition	%	1.34
	8214096	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.59	CHEMBL3831	Homo sapiens	Inhibition	%	2.59
	8214457	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	17.82	CHEMBL3831	Homo sapiens	Inhibition	%	17.82
	8214591	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.4	CHEMBL3831	Homo sapiens	Inhibition	%	0.4
	8214967	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.23	CHEMBL3831	Homo sapiens	Inhibition	%	4.23
	8215218	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.08	CHEMBL3831	Homo sapiens	Inhibition	%	3.08
	8215371	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.26	CHEMBL3831	Homo sapiens	Inhibition	%	2.26
	8215759	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-0.27	CHEMBL3831	Homo sapiens	Inhibition	%	-0.27
	8215878	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.97	CHEMBL3831	Homo sapiens	Inhibition	%	1.97
	8216102	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.35	CHEMBL3831	Homo sapiens	Inhibition	%	1.35
	8216221	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.38	CHEMBL3831	Homo sapiens	Inhibition	%	-0.38
	8216581	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.04	CHEMBL3831	Homo sapiens	Inhibition	%	5.04
	8216719	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.24	CHEMBL3831	Homo sapiens	Inhibition	%	2.24
	8216943	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.71	CHEMBL3831	Homo sapiens	Inhibition	%	-0.71
	8217077	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.69	CHEMBL3831	Homo sapiens	Inhibition	%	1.69
	8217251	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.89	CHEMBL3831	Homo sapiens	Inhibition	%	-0.89
	8217475	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.42	CHEMBL3831	Homo sapiens	Inhibition	%	0.42
	8217606	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	25.93	CHEMBL3831	Homo sapiens	Inhibition	%	25.93
	8217931	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.17	CHEMBL3831	Homo sapiens	Inhibition	%	2.17
	8218270	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.92	CHEMBL3831	Homo sapiens	Inhibition	%	0.92
	8218397	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.55	CHEMBL3831	Homo sapiens	Inhibition	%	1.55
	8218764	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.01	CHEMBL3831	Homo sapiens	Inhibition	%	0.01
	8218895	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	3.99	CHEMBL3831	Homo sapiens	Inhibition	%	3.99
	8219119	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-0.01	CHEMBL3831	Homo sapiens	Inhibition	%	-0.01
	8219279	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.97	CHEMBL3831	Homo sapiens	Inhibition	%	6.97
	8219529	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.26	CHEMBL3831	Homo sapiens	Inhibition	%	1.26
	8219690	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.91	CHEMBL3831	Homo sapiens	Inhibition	%	0.91
	8219914	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.28	CHEMBL3831	Homo sapiens	Inhibition	%	2.28
	8220083	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.59	CHEMBL3831	Homo sapiens	Inhibition	%	0.59
	8220436	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.72	CHEMBL3831	Homo sapiens	Inhibition	%	2.72
	8220550	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.94	CHEMBL3831	Homo sapiens	Inhibition	%	-0.94
	8220774	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.6	CHEMBL3831	Homo sapiens	Inhibition	%	1.6
	8220912	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	23.97	CHEMBL3831	Homo sapiens	Inhibition	%	23.97
	8221272	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	14.91	CHEMBL3831	Homo sapiens	Inhibition	%	14.91
	8221405	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.11	CHEMBL3831	Homo sapiens	Inhibition	%	1.11
	8221794	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.08	CHEMBL3831	Homo sapiens	Inhibition	%	0.08
	8221925	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	70.7	CHEMBL3831	Homo sapiens	Inhibition	%	70.7
	8222247	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-1.1	CHEMBL3831	Homo sapiens	Inhibition	%	-1.1
	8222605	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.35	CHEMBL3831	Homo sapiens	Inhibition	%	2.35
	8222723	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	11.94	CHEMBL3831	Homo sapiens	Inhibition	%	11.94
	8222947	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.75	CHEMBL3831	Homo sapiens	Inhibition	%	0.75
	8223091	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.81	CHEMBL3831	Homo sapiens	Inhibition	%	0.81
	8223444	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.49	CHEMBL3831	Homo sapiens	Inhibition	%	1.49
	8223605	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.26	CHEMBL3831	Homo sapiens	Inhibition	%	1.26
	8223855	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.73	CHEMBL3831	Homo sapiens	Inhibition	%	0.73
	8224241	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.13	CHEMBL3831	Homo sapiens	Inhibition	%	0.13
	8224411	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-1.11	CHEMBL3831	Homo sapiens	Inhibition	%	-1.11
	8224770	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-0.81	CHEMBL3831	Homo sapiens	Inhibition	%	-0.81
	8225108	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.38	CHEMBL3831	Homo sapiens	Inhibition	%	5.38
	8225242	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.86	CHEMBL3831	Homo sapiens	Inhibition	%	1.86
	8225604	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.71	CHEMBL3831	Homo sapiens	Inhibition	%	2.71
	8225739	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.36	CHEMBL3831	Homo sapiens	Inhibition	%	3.36
	8225963	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.3	CHEMBL3831	Homo sapiens	Inhibition	%	1.3
	8226121	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.35	CHEMBL3831	Homo sapiens	Inhibition	%	0.35
	8226246	CHEMBL1961984	GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.67	CHEMBL3831	Homo sapiens	Inhibition	%	1.67
	8226470	CHEMBL1961985	GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.86	CHEMBL3831	Homo sapiens	Inhibition	%	8.86
inactive	9636307	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636308	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
inactive	9636309	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636310	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636311	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636312	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
inactive	9636313	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636314	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636315	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636316	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
active	9636317	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9636318	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636319	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
inactive	9636320	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636321	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9636322	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636323	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9636324	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9636325	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9636326	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
inactive	9636327	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636328	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636329	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636330	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636331	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636332	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9636333	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636334	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9636335	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
inactive	9636336	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636337	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9636338	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636339	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636340	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9636341	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9636342	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636343	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9636344	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9636345	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636346	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9636347	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636348	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636349	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636350	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9636351	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636352	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636353	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636354	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636355	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636356	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
inactive	9636357	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636358	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636359	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9636360	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636361	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636362	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636363	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	199.53	CHEMBL3831	Homo sapiens	pKi		6.7
inactive	9636364	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636365	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636366	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	199.53	CHEMBL3831	Homo sapiens	pKi		6.7
inactive	9636367	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636368	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636369	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636370	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636371	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(Nc2c(C(=O)O)n(CCCOc3cccc4ccccc34)c3cccc(-c4ccccc4C)c23)cc1		CHEMBL1978645	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9636372	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636373	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636374	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636375	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9636376	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9636377	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636378	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
inactive	9636379	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636380	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636381	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9636382	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9636383	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9636384	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9636385	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636386	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636387	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636388	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9636389	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636390	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636391	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636392	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636393	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636394	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636395	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
inactive	9636396	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636397	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9636398	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636399	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
active	9636400	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
active	9636401	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9636402	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636403	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636404	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636405	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636406	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636407	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636408	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9636409	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636410	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636411	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9636412	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9636413	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636414	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636415	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636416	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636417	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	158.49	CHEMBL3831	Homo sapiens	pKi		6.8
inactive	9636418	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636419	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636420	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636421	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636422	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636423	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636424	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9636425	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636426	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636427	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636428	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636429	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636430	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636431	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	7.943	CHEMBL3831	Homo sapiens	pKi		8.1
active	9636432	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9636433	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
active	9636434	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9636435	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9636436	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636437	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9636438	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9636439	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636440	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636441	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636442	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9636443	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
active	9636444	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	199.53	CHEMBL3831	Homo sapiens	pKi		6.7
active	9636445	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9636446	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9636447	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636448	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636449	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636450	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636451	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636452	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636453	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636454	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636455	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636456	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9636457	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636458	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636459	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9636460	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636461	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636462	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636463	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636464	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636465	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9636466	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9636467	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9636468	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9636469	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636470	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9636471	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9636472	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
inactive	9636473	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636474	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9636475	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
inactive	9636476	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636477	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636478	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9636479	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636480	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	125.89	CHEMBL3831	Homo sapiens	pKi		6.9
inactive	9636481	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636482	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636483	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636484	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636485	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
inactive	9636486	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636487	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636488	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636489	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636490	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9636491	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636492	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636493	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636494	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636495	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636496	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9636497	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
inactive	9636498	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636499	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636500	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636501	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9636502	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9636503	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636504	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636505	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636506	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636507	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636508	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636509	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636510	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9636511	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636512	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636513	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636514	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636515	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636516	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9636517	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636518	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636519	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCn1c(=C(C#N)C(=O)O)sc(=CNc2ccccc2)c1=O		CHEMBL1986996	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9636520	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636521	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9636522	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636523	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9636524	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9636525	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636526	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636527	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
active	9636528	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9636529	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9636530	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636531	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
active	9636532	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
active	9636533	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
active	9636534	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9636535	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636536	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
active	9636537	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9636538	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9636539	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636540	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9636541	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640541	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9640542	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640543	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9640544	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640545	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
inactive	9640546	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640547	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640548	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	50.12	CHEMBL3831	Homo sapiens	pKi		7.3
active	9640549	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
active	9640550	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	39.81	CHEMBL3831	Homo sapiens	pKi		7.4
inactive	9640551	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640552	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640553	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640554	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccc(Br)cc1)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1990179	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
inactive	9640555	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640556	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640557	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640558	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640559	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640560	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640561	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640562	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640563	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
active	9640564	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	15.85	CHEMBL3831	Homo sapiens	pKi		7.8
active	9640565	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9640566	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9640567	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640568	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640569	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
inactive	9640570	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640571	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9640572	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640573	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9640574	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9640575	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640576	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
active	9640577	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9640578	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
active	9640579	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	199.53	CHEMBL3831	Homo sapiens	pKi		6.7
inactive	9640580	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640581	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
inactive	9640582	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640583	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL1985507	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640584	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640585	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640586	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640587	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9640588	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640589	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640590	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Fc1ccc2c(c1)-c1n[nH]cc1CS2		CHEMBL1989069	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9640591	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9640592	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9640593	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640594	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640595	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640596	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640597	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
active	9640598	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
active	9640599	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9640600	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640601	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9640602	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640603	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	15.85	CHEMBL3831	Homo sapiens	pKi		7.8
inactive	9640604	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640605	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640606	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640607	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
inactive	9640608	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640609	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9640610	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640611	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640612	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640613	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
inactive	9640614	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640615	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640616	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640617	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640618	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640619	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	199.53	CHEMBL3831	Homo sapiens	pKi		6.7
inactive	9640620	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640621	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640622	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
active	9640623	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
inactive	9640624	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640625	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640626	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640627	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
inactive	9640628	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640629	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9640630	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640631	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640632	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640633	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	63.1	CHEMBL3831	Homo sapiens	pKi		7.2
inactive	9640634	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640635	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640636	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640637	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
inactive	9640638	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640639	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9640640	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
active	9640641	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9640642	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	158.49	CHEMBL3831	Homo sapiens	pKi		6.8
active	9640643	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
active	9640644	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9640645	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
active	9640646	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640647	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640648	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640649	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
active	9640650	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9640651	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640652	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640653	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640654	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640655	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640656	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640657	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9640658	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640659	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640660	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	199.53	CHEMBL3831	Homo sapiens	pKi		6.7
inactive	9640661	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640662	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640663	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640664	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
inactive	9640665	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640666	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9640667	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640668	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640669	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640670	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640671	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9640672	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640673	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640674	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640675	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9640676	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640677	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640678	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640679	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640680	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640681	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9640682	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640683	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640684	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9640685	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640686	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640687	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640688	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640689	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640690	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640691	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640692	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
active	9640693	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
active	9640694	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	158.49	CHEMBL3831	Homo sapiens	pKi		6.8
inactive	9640695	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640696	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
active	9640697	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2c1C(c1ccccc1Br)C(C#N)=C(N)O2		CHEMBL2005214	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640698	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640699	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640700	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640701	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640702	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640703	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640704	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640705	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640706	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9640707	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640708	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640709	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640710	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640711	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640712	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
active	9640713	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
active	9640714	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
active	9640715	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640716	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640717	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640718	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	125.89	CHEMBL3831	Homo sapiens	pKi		6.9
inactive	9640719	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640720	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640721	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640722	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640723	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640724	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640725	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640726	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640727	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640728	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640729	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
active	9640730	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640731	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640732	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640733	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640734	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640735	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640736	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640737	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640738	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9640739	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640740	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640741	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
active	9640742	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9640743	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCc1ccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)cc1		CHEMBL1984869	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9640744	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640745	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9640746	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640747	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640748	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640749	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9640750	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
inactive	9640751	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640752	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
active	9640753	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9640754	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9640755	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9640756	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640757	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640758	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640759	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640760	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640761	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640762	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	19952.62	CHEMBL3831	Homo sapiens	pKi		4.7
inactive	9640763	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640764	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640765	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9640766	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640767	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640768	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640769	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9640770	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640771	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	15.85	CHEMBL3831	Homo sapiens	pKi		7.8
inactive	9640772	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	19952.62	CHEMBL3831	Homo sapiens	pKi		4.7
inactive	9640773	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9640774	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9640775	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644782	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644783	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9644784	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644785	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
inactive	9644786	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644787	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9644788	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9644789	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9644790	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9644791	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644792	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	50.12	CHEMBL3831	Homo sapiens	pKi		7.3
active	9644793	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
inactive	9644794	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644795	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644796	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644797	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644798	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644799	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
inactive	9644800	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644801	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644802	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644803	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644804	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	199.53	CHEMBL3831	Homo sapiens	pKi		6.7
inactive	9644805	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644806	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644807	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644808	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644809	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
inactive	9644810	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644811	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644812	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644813	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644814	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
inactive	9644815	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644816	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644817	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
active	9644818	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9644819	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	63.1	CHEMBL3831	Homo sapiens	pKi		7.2
active	9644820	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9644821	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644822	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	25.12	CHEMBL3831	Homo sapiens	pKi		7.6
active	9644823	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
active	9644824	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	63.1	CHEMBL3831	Homo sapiens	pKi		7.2
active	9644825	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
inactive	9644826	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644827	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9644828	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644829	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
active	9644830	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9644831	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644832	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644833	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644834	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	50.12	CHEMBL3831	Homo sapiens	pKi		7.3
active	9644835	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	158.49	CHEMBL3831	Homo sapiens	pKi		6.8
inactive	9644836	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644837	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
active	9644838	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9644839	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9644840	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
inactive	9644841	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644842	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644843	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644844	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644845	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9644846	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644847	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644848	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9644849	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9644850	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644851	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644852	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644853	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644854	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9644855	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644856	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644857	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644858	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644859	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644860	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644861	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644862	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644863	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
active	9644864	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
active	9644865	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9644866	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644867	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	1000.0	CHEMBL3831	Homo sapiens	pKi		6.0
active	9644868	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
active	9644869	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9644870	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644871	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9644872	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644873	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
inactive	9644874	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644875	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644876	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644877	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	316.23	CHEMBL3831	Homo sapiens	pKi		6.5
inactive	9644878	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644879	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644880	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	398.11	CHEMBL3831	Homo sapiens	pKi		6.4
inactive	9644881	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644882	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644883	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644884	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644885	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644886	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644887	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9644888	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644889	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	=	Ki	nM	6309.57	CHEMBL3831	Homo sapiens	pKi		5.2
inactive	9644890	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644891	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9644892	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644893	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
inactive	9644894	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644895	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9644896	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644897	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644898	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	251.19	CHEMBL3831	Homo sapiens	pKi		6.6
inactive	9644899	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644900	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9644901	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
inactive	9644902	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644903	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9644904	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9644905	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9644906	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695254	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695255	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	1995.26	CHEMBL3831	Homo sapiens	pKi		5.7
inactive	9695256	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695257	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695258	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	39.81	CHEMBL3831	Homo sapiens	pKi		7.4
active	9695259	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
inactive	9695260	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695261	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9695262	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9695263	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695264	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9695265	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695266	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695267	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
active	9695268	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
inactive	9695269	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695270	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695271	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695272	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695273	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695274	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695275	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695276	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9695277	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695278	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccccc1-c1cccc2c1c(Nc1ccccc1)c(C(=O)O)n2CCCOc1cccc2ccccc12		CHEMBL2001646	=	Ki	nM	1584.89	CHEMBL3831	Homo sapiens	pKi		5.8
inactive	9695279	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695280	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	630.96	CHEMBL3831	Homo sapiens	pKi		6.2
active	9695281	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
inactive	9695282	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695283	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695284	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695285	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695286	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	3981.07	CHEMBL3831	Homo sapiens	pKi		5.4
active	9695287	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9695288	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695289	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695290	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
active	9695291	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	5011.87	CHEMBL3831	Homo sapiens	pKi		5.3
active	9695292	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
active	9695293	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1258.93	CHEMBL3831	Homo sapiens	pKi		5.9
inactive	9695294	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695295	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695296	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695297	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695298	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695299	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695300	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695301	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	501.19	CHEMBL3831	Homo sapiens	pKi		6.3
inactive	9695302	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695303	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695304	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695305	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	3162.28	CHEMBL3831	Homo sapiens	pKi		5.5
active	9695306	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	794.33	CHEMBL3831	Homo sapiens	pKi		6.1
active	9695307	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	79.43	CHEMBL3831	Homo sapiens	pKi		7.1
inactive	9695308	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
active	9695309	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	2511.89	CHEMBL3831	Homo sapiens	pKi		5.6
inactive	9695310	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695311	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695312	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
inactive	9695313	CHEMBL1963834	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL3831	Homo sapiens	pKi		5.1
	10839397	CHEMBL2014963	Inhibition of MARK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	52.0	CHEMBL3831	Homo sapiens	INH	%	52.0
	10839537	CHEMBL2016284	Inhibition of MARK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	27.0	CHEMBL3831	Homo sapiens	Activity	%	27.0
	10839545	CHEMBL2015152	Inhibition of MARK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	6.0	CHEMBL3831	Homo sapiens	Activity	%	6.0
	12046355	CHEMBL2157282	Inhibition of MARK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.5	CHEMBL3831	Homo sapiens	INH	%	4.5
	12074692	CHEMBL2161413	Inhibition of PAR-1Ba at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	12170786	CHEMBL2209914	Inhibition of MARK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	89.0	CHEMBL3831	Homo sapiens	Activity	%	89.0
	12170917	CHEMBL2213913	Inhibition of MARK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	95.0	CHEMBL3831	Homo sapiens	Activity	%	95.0
	12172359	CHEMBL2210624	Inhibition of MARK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	12183849	CHEMBL2211539	Inhibition of MARK2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3831	Homo sapiens	pIC50		5.0
	12195383	CHEMBL2209620	Inhibition of recombinant EMK after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	3610.0	CHEMBL3831	Homo sapiens	Ki	nM	3610.0
	12267962	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL3831	Homo sapiens	Residual Activity	%	107.0
	12267963	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	74.0	CHEMBL3831	Homo sapiens	Residual Activity	%	74.0
	12267964	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12267965	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12267966	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12267967	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12267968	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	29.0	CHEMBL3831	Homo sapiens	Residual Activity	%	29.0
	12267969	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12267970	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12267971	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12267972	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	82.0	CHEMBL3831	Homo sapiens	Residual Activity	%	82.0
	12267973	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	86.0	CHEMBL3831	Homo sapiens	Residual Activity	%	86.0
	12267974	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	94.0	CHEMBL3831	Homo sapiens	Residual Activity	%	94.0
	12267975	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	111.0	CHEMBL3831	Homo sapiens	Residual Activity	%	111.0
	12267976	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	74.0	CHEMBL3831	Homo sapiens	Residual Activity	%	74.0
	12267977	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	92.0	CHEMBL3831	Homo sapiens	Residual Activity	%	92.0
	12267978	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12267979	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	90.0	CHEMBL3831	Homo sapiens	Residual Activity	%	90.0
	12267980	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	90.0	CHEMBL3831	Homo sapiens	Residual Activity	%	90.0
	12267981	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	40.0	CHEMBL3831	Homo sapiens	Residual Activity	%	40.0
	12267982	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12267983	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	113.0	CHEMBL3831	Homo sapiens	Residual Activity	%	113.0
	12267984	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	99.0	CHEMBL3831	Homo sapiens	Residual Activity	%	99.0
	12267985	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	100.0	CHEMBL3831	Homo sapiens	Residual Activity	%	100.0
	12267986	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	105.0	CHEMBL3831	Homo sapiens	Residual Activity	%	105.0
	12267987	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12267988	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	40.0	CHEMBL3831	Homo sapiens	Residual Activity	%	40.0
	12267989	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12267990	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12267991	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	75.0	CHEMBL3831	Homo sapiens	Residual Activity	%	75.0
	12267992	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL3831	Homo sapiens	Residual Activity	%	90.0
	12267993	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12267994	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12267995	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12267996	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12267997	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12267998	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	90.0	CHEMBL3831	Homo sapiens	Residual Activity	%	90.0
	12267999	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	111.0	CHEMBL3831	Homo sapiens	Residual Activity	%	111.0
	12268000	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12268001	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	81.0	CHEMBL3831	Homo sapiens	Residual Activity	%	81.0
	12268002	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12268003	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	93.0	CHEMBL3831	Homo sapiens	Residual Activity	%	93.0
	12268004	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	5.0	CHEMBL3831	Homo sapiens	Residual Activity	%	5.0
	12268005	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL3831	Homo sapiens	Residual Activity	%	1.0
	12268006	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	105.0	CHEMBL3831	Homo sapiens	Residual Activity	%	105.0
	12268007	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12268008	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	99.0	CHEMBL3831	Homo sapiens	Residual Activity	%	99.0
	12268009	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	78.0	CHEMBL3831	Homo sapiens	Residual Activity	%	78.0
	12268010	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12268011	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	91.0	CHEMBL3831	Homo sapiens	Residual Activity	%	91.0
	12268012	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	64.0	CHEMBL3831	Homo sapiens	Residual Activity	%	64.0
	12268013	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	84.0	CHEMBL3831	Homo sapiens	Residual Activity	%	84.0
	12268014	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	10.0	CHEMBL3831	Homo sapiens	Residual Activity	%	10.0
	12268015	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12268016	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12268017	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12268018	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12268019	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	100.0	CHEMBL3831	Homo sapiens	Residual Activity	%	100.0
	12268020	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	87.0	CHEMBL3831	Homo sapiens	Residual Activity	%	87.0
	12268021	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12268022	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL3831	Homo sapiens	Residual Activity	%	75.0
	12268023	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	0.0	CHEMBL3831	Homo sapiens	Residual Activity	%	0.0
	12268024	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12268025	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	89.0	CHEMBL3831	Homo sapiens	Residual Activity	%	89.0
	12268026	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	105.0	CHEMBL3831	Homo sapiens	Residual Activity	%	105.0
	12268027	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	82.0	CHEMBL3831	Homo sapiens	Residual Activity	%	82.0
	12268028	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	114.0	CHEMBL3831	Homo sapiens	Residual Activity	%	114.0
	12268029	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12268030	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12268031	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12268032	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12268033	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	91.0	CHEMBL3831	Homo sapiens	Residual Activity	%	91.0
	12268034	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	67.0	CHEMBL3831	Homo sapiens	Residual Activity	%	67.0
	12268035	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	121.0	CHEMBL3831	Homo sapiens	Residual Activity	%	121.0
	12268036	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	81.0	CHEMBL3831	Homo sapiens	Residual Activity	%	81.0
	12268037	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	48.0	CHEMBL3831	Homo sapiens	Residual Activity	%	48.0
	12268038	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12268039	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	11.0	CHEMBL3831	Homo sapiens	Residual Activity	%	11.0
	12268040	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	95.0	CHEMBL3831	Homo sapiens	Residual Activity	%	95.0
	12268041	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3831	Homo sapiens	Residual Activity	%	0.0
	12268042	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12268043	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	46.0	CHEMBL3831	Homo sapiens	Residual Activity	%	46.0
	12268044	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	77.0	CHEMBL3831	Homo sapiens	Residual Activity	%	77.0
	12268045	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12268046	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12268047	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12268048	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	111.0	CHEMBL3831	Homo sapiens	Residual Activity	%	111.0
	12268049	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12268050	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12268051	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	48.0	CHEMBL3831	Homo sapiens	Residual Activity	%	48.0
	12268052	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12268053	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	107.0	CHEMBL3831	Homo sapiens	Residual Activity	%	107.0
	12268054	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	80.0	CHEMBL3831	Homo sapiens	Residual Activity	%	80.0
	12268055	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12268056	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12268057	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	99.0	CHEMBL3831	Homo sapiens	Residual Activity	%	99.0
	12268058	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12268059	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12269700	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269701	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12269702	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	40.0	CHEMBL3831	Homo sapiens	Residual Activity	%	40.0
	12269703	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL3831	Homo sapiens	Residual Activity	%	1.0
	12269704	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	95.0	CHEMBL3831	Homo sapiens	Residual Activity	%	95.0
	12269705	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	63.0	CHEMBL3831	Homo sapiens	Residual Activity	%	63.0
	12269706	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	58.0	CHEMBL3831	Homo sapiens	Residual Activity	%	58.0
	12269707	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12269708	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269709	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	105.0	CHEMBL3831	Homo sapiens	Residual Activity	%	105.0
	12269710	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12269711	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	62.0	CHEMBL3831	Homo sapiens	Residual Activity	%	62.0
	12269712	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12269713	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12269714	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	38.0	CHEMBL3831	Homo sapiens	Residual Activity	%	38.0
	12269715	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	113.0	CHEMBL3831	Homo sapiens	Residual Activity	%	113.0
	12269716	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12269717	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12269718	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	80.0	CHEMBL3831	Homo sapiens	Residual Activity	%	80.0
	12269719	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	109.0	CHEMBL3831	Homo sapiens	Residual Activity	%	109.0
	12269720	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269721	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12269722	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	79.0	CHEMBL3831	Homo sapiens	Residual Activity	%	79.0
	12269723	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	90.0	CHEMBL3831	Homo sapiens	Residual Activity	%	90.0
	12269724	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	80.0	CHEMBL3831	Homo sapiens	Residual Activity	%	80.0
	12269725	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	22.0	CHEMBL3831	Homo sapiens	Residual Activity	%	22.0
	12269726	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	58.0	CHEMBL3831	Homo sapiens	Residual Activity	%	58.0
	12269727	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12269728	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	95.0	CHEMBL3831	Homo sapiens	Residual Activity	%	95.0
	12269729	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269730	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	84.0	CHEMBL3831	Homo sapiens	Residual Activity	%	84.0
	12269731	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL3831	Homo sapiens	Residual Activity	%	4.0
	12269732	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	99.0	CHEMBL3831	Homo sapiens	Residual Activity	%	99.0
	12269733	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269734	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	55.0	CHEMBL3831	Homo sapiens	Residual Activity	%	55.0
	12269735	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269736	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	66.0	CHEMBL3831	Homo sapiens	Residual Activity	%	66.0
	12269737	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	93.0	CHEMBL3831	Homo sapiens	Residual Activity	%	93.0
	12269738	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12269739	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	77.0	CHEMBL3831	Homo sapiens	Residual Activity	%	77.0
	12269740	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	18.0	CHEMBL3831	Homo sapiens	Residual Activity	%	18.0
	12269741	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269742	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	65.0	CHEMBL3831	Homo sapiens	Residual Activity	%	65.0
	12269743	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	88.0	CHEMBL3831	Homo sapiens	Residual Activity	%	88.0
	12269744	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	83.0	CHEMBL3831	Homo sapiens	Residual Activity	%	83.0
	12269745	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	81.0	CHEMBL3831	Homo sapiens	Residual Activity	%	81.0
	12269746	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	113.0	CHEMBL3831	Homo sapiens	Residual Activity	%	113.0
	12269747	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12269748	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	92.0	CHEMBL3831	Homo sapiens	Residual Activity	%	92.0
	12269749	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12269750	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	105.0	CHEMBL3831	Homo sapiens	Residual Activity	%	105.0
	12269751	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12269752	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	41.0	CHEMBL3831	Homo sapiens	Residual Activity	%	41.0
	12269753	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	118.0	CHEMBL3831	Homo sapiens	Residual Activity	%	118.0
	12269754	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL3831	Homo sapiens	Residual Activity	%	105.0
	12269755	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	86.0	CHEMBL3831	Homo sapiens	Residual Activity	%	86.0
	12269756	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12269757	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	79.0	CHEMBL3831	Homo sapiens	Residual Activity	%	79.0
	12269758	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269759	CHEMBL2219367	Millipore: Percentage of residual kinase activity of MARK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	-2.0	CHEMBL3831	Homo sapiens	Residual Activity	%	-2.0
	12269760	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	111.0	CHEMBL3831	Homo sapiens	Residual Activity	%	111.0
	12269761	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	33.0	CHEMBL3831	Homo sapiens	Residual Activity	%	33.0
	12269762	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269763	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12269764	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269765	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269766	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	25.0	CHEMBL3831	Homo sapiens	Residual Activity	%	25.0
	12269767	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	100.0	CHEMBL3831	Homo sapiens	Residual Activity	%	100.0
	12269768	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	107.0	CHEMBL3831	Homo sapiens	Residual Activity	%	107.0
	12269769	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	100.0	CHEMBL3831	Homo sapiens	Residual Activity	%	100.0
	12269770	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12269771	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	107.0	CHEMBL3831	Homo sapiens	Residual Activity	%	107.0
	12269772	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269773	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269774	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	42.0	CHEMBL3831	Homo sapiens	Residual Activity	%	42.0
	12269775	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	109.0	CHEMBL3831	Homo sapiens	Residual Activity	%	109.0
	12269776	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12269777	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12269778	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	108.0	CHEMBL3831	Homo sapiens	Residual Activity	%	108.0
	12269779	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	14.0	CHEMBL3831	Homo sapiens	Residual Activity	%	14.0
	12269780	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269781	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269782	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12269783	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	105.0	CHEMBL3831	Homo sapiens	Residual Activity	%	105.0
	12269784	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269785	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269786	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	17.0	CHEMBL3831	Homo sapiens	Residual Activity	%	17.0
	12269787	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	77.0	CHEMBL3831	Homo sapiens	Residual Activity	%	77.0
	12269788	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269789	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	68.0	CHEMBL3831	Homo sapiens	Residual Activity	%	68.0
	12269790	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	109.0	CHEMBL3831	Homo sapiens	Residual Activity	%	109.0
	12269791	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12269792	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	95.0	CHEMBL3831	Homo sapiens	Residual Activity	%	95.0
	12269793	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	113.0	CHEMBL3831	Homo sapiens	Residual Activity	%	113.0
	12269794	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	93.0	CHEMBL3831	Homo sapiens	Residual Activity	%	93.0
	12269795	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269796	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	73.0	CHEMBL3831	Homo sapiens	Residual Activity	%	73.0
	12269797	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269798	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269799	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	91.0	CHEMBL3831	Homo sapiens	Residual Activity	%	91.0
	12269800	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	113.0	CHEMBL3831	Homo sapiens	Residual Activity	%	113.0
	12269801	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269802	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	9.0	CHEMBL3831	Homo sapiens	Residual Activity	%	9.0
	12269803	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	2.0	CHEMBL3831	Homo sapiens	Residual Activity	%	2.0
	12269804	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	107.0	CHEMBL3831	Homo sapiens	Residual Activity	%	107.0
	12269805	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	89.0	CHEMBL3831	Homo sapiens	Residual Activity	%	89.0
	12269806	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL3831	Homo sapiens	Residual Activity	%	103.0
	12269807	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	84.0	CHEMBL3831	Homo sapiens	Residual Activity	%	84.0
	12269808	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12269809	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12269810	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	53.0	CHEMBL3831	Homo sapiens	Residual Activity	%	53.0
	12269811	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	90.0	CHEMBL3831	Homo sapiens	Residual Activity	%	90.0
	12269812	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL3831	Homo sapiens	Residual Activity	%	4.0
	12269813	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	55.0	CHEMBL3831	Homo sapiens	Residual Activity	%	55.0
	12269814	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	111.0	CHEMBL3831	Homo sapiens	Residual Activity	%	111.0
	12269815	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269816	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269817	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	109.0	CHEMBL3831	Homo sapiens	Residual Activity	%	109.0
	12269818	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	71.0	CHEMBL3831	Homo sapiens	Residual Activity	%	71.0
	12269819	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	95.0	CHEMBL3831	Homo sapiens	Residual Activity	%	95.0
	12269820	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	36.0	CHEMBL3831	Homo sapiens	Residual Activity	%	36.0
	12269821	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	2.0	CHEMBL3831	Homo sapiens	Residual Activity	%	2.0
	12269822	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	107.0	CHEMBL3831	Homo sapiens	Residual Activity	%	107.0
	12269823	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12269824	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	107.0	CHEMBL3831	Homo sapiens	Residual Activity	%	107.0
	12269825	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	66.0	CHEMBL3831	Homo sapiens	Residual Activity	%	66.0
	12269826	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12269827	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269828	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269829	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269830	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	114.0	CHEMBL3831	Homo sapiens	Residual Activity	%	114.0
	12269831	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	71.0	CHEMBL3831	Homo sapiens	Residual Activity	%	71.0
	12269832	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	22.0	CHEMBL3831	Homo sapiens	Residual Activity	%	22.0
	12269833	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	110.0	CHEMBL3831	Homo sapiens	Residual Activity	%	110.0
	12269834	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	50.0	CHEMBL3831	Homo sapiens	Residual Activity	%	50.0
	12269835	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	31.0	CHEMBL3831	Homo sapiens	Residual Activity	%	31.0
	12269836	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12269837	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	3.0	CHEMBL3831	Homo sapiens	Residual Activity	%	3.0
	12269838	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269839	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL3831	Homo sapiens	Residual Activity	%	1.0
	12269840	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269841	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	8.0	CHEMBL3831	Homo sapiens	Residual Activity	%	8.0
	12269842	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	52.0	CHEMBL3831	Homo sapiens	Residual Activity	%	52.0
	12269843	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	99.0	CHEMBL3831	Homo sapiens	Residual Activity	%	99.0
	12269844	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	81.0	CHEMBL3831	Homo sapiens	Residual Activity	%	81.0
	12269845	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	95.0	CHEMBL3831	Homo sapiens	Residual Activity	%	95.0
	12269846	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269847	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269848	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL3831	Homo sapiens	Residual Activity	%	94.0
	12269849	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	14.0	CHEMBL3831	Homo sapiens	Residual Activity	%	14.0
	12269850	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	91.0	CHEMBL3831	Homo sapiens	Residual Activity	%	91.0
	12269851	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL3831	Homo sapiens	Residual Activity	%	98.0
	12269852	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	27.0	CHEMBL3831	Homo sapiens	Residual Activity	%	27.0
	12269853	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	99.0	CHEMBL3831	Homo sapiens	Residual Activity	%	99.0
	12269854	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	104.0	CHEMBL3831	Homo sapiens	Residual Activity	%	104.0
	12269855	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	93.0	CHEMBL3831	Homo sapiens	Residual Activity	%	93.0
	12269856	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	86.0	CHEMBL3831	Homo sapiens	Residual Activity	%	86.0
	12269857	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL3831	Homo sapiens	Residual Activity	%	90.0
	12269858	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	91.0	CHEMBL3831	Homo sapiens	Residual Activity	%	91.0
	12269859	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269860	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	20.0	CHEMBL3831	Homo sapiens	Residual Activity	%	20.0
	12269861	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-2.0	CHEMBL3831	Homo sapiens	Residual Activity	%	-2.0
	12269862	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL3831	Homo sapiens	Residual Activity	%	94.0
	12269863	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	36.0	CHEMBL3831	Homo sapiens	Residual Activity	%	36.0
	12269864	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	56.0	CHEMBL3831	Homo sapiens	Residual Activity	%	56.0
	12269865	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12269866	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	94.0	CHEMBL3831	Homo sapiens	Residual Activity	%	94.0
	12269867	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12269868	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269869	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	23.0	CHEMBL3831	Homo sapiens	Residual Activity	%	23.0
	12269870	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269871	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269872	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	11.0	CHEMBL3831	Homo sapiens	Residual Activity	%	11.0
	12269873	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	87.0	CHEMBL3831	Homo sapiens	Residual Activity	%	87.0
	12269874	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	92.0	CHEMBL3831	Homo sapiens	Residual Activity	%	92.0
	12269875	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269876	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	28.0	CHEMBL3831	Homo sapiens	Residual Activity	%	28.0
	12269877	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269878	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	101.0	CHEMBL3831	Homo sapiens	Residual Activity	%	101.0
	12269879	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL3831	Homo sapiens	Residual Activity	%	102.0
	12269880	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	69.0	CHEMBL3831	Homo sapiens	Residual Activity	%	69.0
	12269881	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	47.0	CHEMBL3831	Homo sapiens	Residual Activity	%	47.0
	12269882	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	52.0	CHEMBL3831	Homo sapiens	Residual Activity	%	52.0
	12269883	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	13.0	CHEMBL3831	Homo sapiens	Residual Activity	%	13.0
	12269884	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	29.0	CHEMBL3831	Homo sapiens	Residual Activity	%	29.0
	12269885	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269886	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	52.0	CHEMBL3831	Homo sapiens	Residual Activity	%	52.0
	12269887	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL3831	Homo sapiens	Residual Activity	%	100.0
	12269888	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	77.0	CHEMBL3831	Homo sapiens	Residual Activity	%	77.0
	12269889	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL3831	Homo sapiens	Residual Activity	%	-1.0
	12269890	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	91.0	CHEMBL3831	Homo sapiens	Residual Activity	%	91.0
	12269891	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	92.0	CHEMBL3831	Homo sapiens	Residual Activity	%	92.0
	12269892	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	12.0	CHEMBL3831	Homo sapiens	Residual Activity	%	12.0
	12269893	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL3831	Homo sapiens	Residual Activity	%	96.0
	12269894	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	18.0	CHEMBL3831	Homo sapiens	Residual Activity	%	18.0
	12269895	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	48.0	CHEMBL3831	Homo sapiens	Residual Activity	%	48.0
	12269896	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	86.0	CHEMBL3831	Homo sapiens	Residual Activity	%	86.0
	12269897	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	22.0	CHEMBL3831	Homo sapiens	Residual Activity	%	22.0
	12269898	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	3.0	CHEMBL3831	Homo sapiens	Residual Activity	%	3.0
	12269899	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	92.0	CHEMBL3831	Homo sapiens	Residual Activity	%	92.0
	12269900	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	53.0	CHEMBL3831	Homo sapiens	Residual Activity	%	53.0
	12269901	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	47.0	CHEMBL3831	Homo sapiens	Residual Activity	%	47.0
	12269902	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	46.0	CHEMBL3831	Homo sapiens	Residual Activity	%	46.0
	12269903	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	24.0	CHEMBL3831	Homo sapiens	Residual Activity	%	24.0
	12269904	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12269905	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	52.0	CHEMBL3831	Homo sapiens	Residual Activity	%	52.0
	12269906	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	44.0	CHEMBL3831	Homo sapiens	Residual Activity	%	44.0
	12269907	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	79.0	CHEMBL3831	Homo sapiens	Residual Activity	%	79.0
	12269908	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	93.0	CHEMBL3831	Homo sapiens	Residual Activity	%	93.0
	12269909	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	94.0	CHEMBL3831	Homo sapiens	Residual Activity	%	94.0
	12269910	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	8.0	CHEMBL3831	Homo sapiens	Residual Activity	%	8.0
	12269911	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	97.0	CHEMBL3831	Homo sapiens	Residual Activity	%	97.0
	12269912	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	106.0	CHEMBL3831	Homo sapiens	Residual Activity	%	106.0
	12269913	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	88.0	CHEMBL3831	Homo sapiens	Residual Activity	%	88.0
	12269914	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	112.0	CHEMBL3831	Homo sapiens	Residual Activity	%	112.0
	12269915	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	72.0	CHEMBL3831	Homo sapiens	Residual Activity	%	72.0
	12269916	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	99.0	CHEMBL3831	Homo sapiens	Residual Activity	%	99.0
	12269917	CHEMBL2219368	Millipore: Percentage of residual kinase activity of MARK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	-3.0	CHEMBL3831	Homo sapiens	Residual Activity	%	-3.0
	12668317	CHEMBL2345071	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	81.0	CHEMBL3831	Homo sapiens	INH	%	81.0
	12668318	CHEMBL2345071	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	87.0	CHEMBL3831	Homo sapiens	INH	%	87.0
	12668319	CHEMBL2345071	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	88.0	CHEMBL3831	Homo sapiens	INH	%	88.0
	12668320	CHEMBL2345071	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	95.0	CHEMBL3831	Homo sapiens	INH	%	95.0
	12668321	CHEMBL2345071	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	53.0	CHEMBL3831	Homo sapiens	INH	%	53.0
	12668322	CHEMBL2345071	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	80.0	CHEMBL3831	Homo sapiens	INH	%	80.0
	12668323	CHEMBL2345071	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	94.0	CHEMBL3831	Homo sapiens	INH	%	94.0
	12672993	CHEMBL2339723	Inhibition of recombinant MARK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	62.0	CHEMBL3831	Homo sapiens	Activity	%	62.0
	12672994	CHEMBL2339723	Inhibition of recombinant MARK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	45.0	CHEMBL3831	Homo sapiens	Activity	%	45.0
	12700132	CHEMBL2342669	Inhibition of recombinant MARK2 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	22.0	CHEMBL3831	Homo sapiens	INH	%	22.0
	12723653	CHEMBL2350752	Inhibition of MARK2 (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	40.0	CHEMBL3831	Homo sapiens	INH	%	40.0
	12724748	CHEMBL2352271	Inhibition of MARK2 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	64.0	CHEMBL3831	Homo sapiens	INH	%	64.0
	12724749	CHEMBL2352271	Inhibition of MARK2 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	52.0	CHEMBL3831	Homo sapiens	INH	%	52.0
	12727737	CHEMBL2351171	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	91.0	CHEMBL3831	Homo sapiens	Activity	%	91.0
	12729025	CHEMBL2351931	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL3831	Homo sapiens	Activity	%	103.0
	12729909	CHEMBL2349814	Inhibition of MARK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	91.0	CHEMBL3831	Homo sapiens	Activity	%	91.0
	12730168	CHEMBL2351171	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL3831	Homo sapiens	Activity	%	92.0
Not Active	13324728	CHEMBL2390475	Activity at MARK2 (unknown origin)	B	O=C(O)c1cccc(CN2C(=O)/C(=C(\c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1		CHEMBL2386114		Activity			CHEMBL3831	Homo sapiens	Activity		
	13375784	CHEMBL2404178	Inhibition of MARK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL3831	Homo sapiens	INH	%	1.0
	13419679	CHEMBL2422099	Inhibition of MARK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	47.0	CHEMBL3831	Homo sapiens	INH	%	47.0
	13419680	CHEMBL2422099	Inhibition of MARK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	60.0	CHEMBL3831	Homo sapiens	INH	%	60.0
	13419681	CHEMBL2422099	Inhibition of MARK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	72.0	CHEMBL3831	Homo sapiens	INH	%	72.0
	13436290	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436291	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436292	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436293	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436294	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436295	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436296	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436297	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436298	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436299	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436300	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13436301	CHEMBL2422249	Inhibition of MARK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	13442334	CHEMBL2429502	Competitive binding affinity to MARK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	13445469	CHEMBL2429502	Competitive binding affinity to MARK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	88.0	CHEMBL3831	Homo sapiens	INH	%	88.0
	13448524	CHEMBL2429502	Competitive binding affinity to MARK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	13448660	CHEMBL2429502	Competitive binding affinity to MARK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	13451455	CHEMBL2429502	Competitive binding affinity to MARK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	78.0	CHEMBL3831	Homo sapiens	INH	%	78.0
	13454640	CHEMBL2429502	Competitive binding affinity to MARK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	13476434	CHEMBL2439116	Inhibition of human wild type MARK2 at 1 uM by qPCR analysis relative to control	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	Inhibition	%	49.0	CHEMBL3831	Homo sapiens	INH	%	49.0
	13871793	CHEMBL3101254	Inhibition of human PAR1Balpha assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	53.0	CHEMBL3831	Homo sapiens	Activity	%	53.0
	13954755	CHEMBL3132486	Inhibition of human PAR-1Balpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	67.0	CHEMBL3831	Homo sapiens	Activity	%	67.0
	13954769	CHEMBL3132486	Inhibition of human PAR-1Balpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	54.0	CHEMBL3831	Homo sapiens	Activity	%	54.0
	13954770	CHEMBL3132486	Inhibition of human PAR-1Balpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	52.0	CHEMBL3831	Homo sapiens	Activity	%	52.0
	13966034	CHEMBL3136649	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	75.0	CHEMBL3831	Homo sapiens	INH	%	75.0
	13973309	CHEMBL3134906	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	2.0	CHEMBL3831	Homo sapiens	INH	%	2.0
	13974027	CHEMBL3136491	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	13974118	CHEMBL3135764	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	73.0	CHEMBL3831	Homo sapiens	INH	%	73.0
	13974209	CHEMBL3134741	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	90.0	CHEMBL3831	Homo sapiens	INH	%	90.0
	13974300	CHEMBL3136852	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	88.0	CHEMBL3831	Homo sapiens	INH	%	88.0
	13975038	CHEMBL3135998	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	13975129	CHEMBL3135725	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	13975220	CHEMBL3136378	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	13975863	CHEMBL3135478	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	37.0	CHEMBL3831	Homo sapiens	INH	%	37.0
	13975956	CHEMBL3137010	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	41.5	CHEMBL3831	Homo sapiens	INH	%	41.5
	13976047	CHEMBL3135403	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	67.0	CHEMBL3831	Homo sapiens	INH	%	67.0
	13976138	CHEMBL3135075	Inhibition of human full length MARK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	61.0	CHEMBL3831	Homo sapiens	INH	%	61.0
	14582547	CHEMBL3242548	Inhibition of human MARK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	100.5	CHEMBL3831	Homo sapiens	Activity	%	100.5
	15018634	CHEMBL3361526	Inhibition of MARK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	4.0	CHEMBL3831	Homo sapiens	INH	%	4.0
	15072445	CHEMBL3380129	Inhibition of MARK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	101.0	CHEMBL3831	Homo sapiens	Activity	%	101.0
	15251833	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	59.0	CHEMBL3831	Homo sapiens	Activity	%	59.0
	15251964	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	55.0	CHEMBL3831	Homo sapiens	Activity	%	55.0
	15252066	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	90.0	CHEMBL3831	Homo sapiens	Activity	%	90.0
	15252711	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	101.0	CHEMBL3831	Homo sapiens	Activity	%	101.0
	15252813	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	82.0	CHEMBL3831	Homo sapiens	Activity	%	82.0
	15252915	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	95.0	CHEMBL3831	Homo sapiens	Activity	%	95.0
	15253589	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	88.0	CHEMBL3831	Homo sapiens	Activity	%	88.0
	15253691	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	89.0	CHEMBL3831	Homo sapiens	Activity	%	89.0
	15253793	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	82.0	CHEMBL3831	Homo sapiens	Activity	%	82.0
	15254459	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	57.0	CHEMBL3831	Homo sapiens	Activity	%	57.0
	15254561	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	82.0	CHEMBL3831	Homo sapiens	Activity	%	82.0
	15255251	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	79.0	CHEMBL3831	Homo sapiens	Activity	%	79.0
	15255354	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	68.0	CHEMBL3831	Homo sapiens	Activity	%	68.0
	15255456	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	85.0	CHEMBL3831	Homo sapiens	Activity	%	85.0
	15256188	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	92.0	CHEMBL3831	Homo sapiens	Activity	%	92.0
	15256290	CHEMBL3428248	Inhibition of MARK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	80.0	CHEMBL3831	Homo sapiens	Activity	%	80.0
	15754247	CHEMBL3631172	Inhibition of MARK2 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	3.0	CHEMBL3831	Homo sapiens	INH	%	3.0
	15756925	CHEMBL3631285	Inhibition of MARK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	3.84	CHEMBL3831	Homo sapiens	INH	%	3.84
	15757798	CHEMBL3631285	Inhibition of MARK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	10.91	CHEMBL3831	Homo sapiens	INH	%	10.91
	15758777	CHEMBL3631285	Inhibition of MARK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	2.7	CHEMBL3831	Homo sapiens	INH	%	2.7
	16431893	CHEMBL3747986	Inhibition of human MARK2 using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3831	Homo sapiens	IC50	uM	10.0
	16451504	CHEMBL3760627	Inhibition of MARK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-5.3	CHEMBL3831	Homo sapiens	INH	%	-5.3
	16495158	CHEMBL3777737	Inhibition of N-terminal His6-tagged recombinant human PAR-1B alpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-15.0	CHEMBL3831	Homo sapiens	Activity	%	-15.0
	16496077	CHEMBL3777737	Inhibition of N-terminal His6-tagged recombinant human PAR-1B alpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	0.0	CHEMBL3831	Homo sapiens	Activity	%	0.0
	16508264	CHEMBL3777737	Inhibition of N-terminal His6-tagged recombinant human PAR-1B alpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	13.0	CHEMBL3831	Homo sapiens	Activity	%	13.0
	16611976	CHEMBL3815473	Inhibition of human MARK2 (2 to 691 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-23.0	CHEMBL3831	Homo sapiens	Activity	%	-23.0
	16614530	CHEMBL3816728	Inhibition of human MARK2 at 1 uM using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-3.0	CHEMBL3831	Homo sapiens	INH	%	-3.0
	16618168	CHEMBL3817263	Inhibition of full length recombinant human GST-tagged MARK2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	16654139	CHEMBL3830815	Inhibition of human MARK2 (2 to 691 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	69.0	CHEMBL3831	Homo sapiens	Activity	%	69.0
Inactive	17917207	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917208	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917209	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917210	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917211	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917212	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	442.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	442.0
Inactive	17917213	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917214	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917215	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917216	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917217	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917218	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917219	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	614.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	614.0
Inactive	17917220	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917221	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917222	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917223	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917224	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917225	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917226	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917227	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917228	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917229	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	2310.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2310.0
Active	17917230	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	300.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	300.0
Active	17917231	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	7728.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	7728.0
Inactive	17917232	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917233	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917234	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917235	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917236	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917237	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917238	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917239	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917240	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	3200.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	3200.0
Inactive	17917241	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917242	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917243	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917244	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917245	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917246	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17917247	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4507.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	4507.0
Inactive	17917248	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917249	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	11103.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	11103.0
Active	17917250	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	2290.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2290.0
Inactive	17917251	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917252	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917253	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917254	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917255	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	2601.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2601.0
Inactive	17917256	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917257	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917258	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917259	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917260	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	6626.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	6626.0
Inactive	17917261	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917262	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917263	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917264	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917265	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917266	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917267	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917268	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917269	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917270	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917271	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917272	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917273	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917274	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917275	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917276	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917277	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917278	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917279	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917280	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	13.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	13.0
Inactive	17917281	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917282	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	=	Kd	nM	6017.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	6017.0
Inactive	17917283	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917284	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917285	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917286	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917287	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917288	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917289	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917290	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917291	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917292	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917293	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	704.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	704.0
Inactive	17917294	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917295	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917296	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917297	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917298	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917299	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1364.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	1364.0
Inactive	17917300	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917301	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	114.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	114.0
Inactive	17917302	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917303	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917304	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917305	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917306	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	125.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	125.0
Inactive	17917307	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917308	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917309	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917310	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917311	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917312	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917313	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917314	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	196.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	196.0
Inactive	17917315	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917316	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917317	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917318	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917319	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917320	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917321	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917322	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917323	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917324	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3013.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	3013.0
Inactive	17917325	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917326	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917327	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917328	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917329	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917330	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917331	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917332	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917333	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917334	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917335	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917336	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917337	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917338	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917339	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2023.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2023.0
Inactive	17917340	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917341	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917342	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917343	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917344	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	351.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	351.0
Active	17917345	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	157.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	157.0
Active	17917346	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	759.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	759.0
Inactive	17917347	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917348	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917349	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917350	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917351	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	365.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	365.0
Inactive	17917352	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917353	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917354	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917355	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917356	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917357	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917358	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917359	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917360	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917361	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917362	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917363	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917364	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917365	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917366	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917367	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	2332.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2332.0
Inactive	17917368	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917369	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917370	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	3147.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	3147.0
Inactive	17917371	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917372	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917373	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	2365.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2365.0
Inactive	17917374	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917375	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917376	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917377	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917378	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917379	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917380	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917381	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917382	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917383	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917384	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917385	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917386	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917387	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	3184.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	3184.0
Inactive	17917388	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917389	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917390	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917391	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917392	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917393	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917394	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917395	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917396	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917397	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917398	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	2174.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2174.0
Inactive	17917399	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917400	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917401	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917402	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	2075.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	2075.0
Inactive	17917403	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917404	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	302.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	302.0
Inactive	17917405	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917406	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917407	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917408	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917409	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917410	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917411	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	4960.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	4960.0
Inactive	17917412	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917413	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917414	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917415	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917416	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917417	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917418	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917419	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917420	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917421	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917422	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917423	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917424	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917425	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917426	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917427	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917428	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917429	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917430	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	580.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	580.0
Inactive	17917431	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917432	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917433	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917434	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917435	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917436	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917437	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917438	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917439	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917440	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917441	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917442	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Active	17917443	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	491.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	491.0
Inactive	17917444	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917445	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917446	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917447	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917448	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917449	CHEMBL3991781	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3831	Homo sapiens	Kd apparent	nM	30000.0
	18114265	CHEMBL4025229	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL3831	Homo sapiens	Activity	%	99.0
	18153012	CHEMBL4034533	Inhibition of MARK2 (unknown origin) labeling at conserved Lysine2 at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-10.1	CHEMBL3831	Homo sapiens	INH	%	-10.1
	18153073	CHEMBL4034391	Inhibition of MARK2 (unknown origin) labeling at Lysine1 at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-6.8	CHEMBL3831	Homo sapiens	INH	%	-6.8
	18153198	CHEMBL4034532	Inhibition of MARK2 (unknown origin) labeling at conserved Lysine2 (EVAVKIIDKT) at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-7.2	CHEMBL3831	Homo sapiens	INH	%	-7.2
	18153279	CHEMBL4034392	Inhibition of MARK2 (unknown origin) labeling at conserved Lysine2 (EVAVKIIDK) at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-6.8	CHEMBL3831	Homo sapiens	INH	%	-6.8
	18203753	CHEMBL4044040	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	90.0	CHEMBL3831	Homo sapiens	Activity	%	90.0
	18211560	CHEMBL4045753	Inhibition of MARK2 conserved Lys2 (DLKAENLLLDADMNIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	28.8	CHEMBL3831	Homo sapiens	INH	%	28.8
	18211561	CHEMBL4045752	Inhibition of MARK2 conserved Lys1 (EVAVKIIDKTQLNSSSLQK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-35.0	CHEMBL3831	Homo sapiens	INH	%	-35.0
	18211562	CHEMBL4045751	Inhibition of MARK2 conserved Lys1 (EVAVKIIDK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-34.1	CHEMBL3831	Homo sapiens	INH	%	-34.1
	18211896	CHEMBL4045992	Inhibition of MARK2 conserved Lys1 (EVAVKIIDK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-33.1	CHEMBL3831	Homo sapiens	INH	%	-33.1
	18211897	CHEMBL4045993	Inhibition of MARK2 conserved Lys1 (EVAVKIIDKTQLNSSSLQK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-20.7	CHEMBL3831	Homo sapiens	INH	%	-20.7
	18211898	CHEMBL4045994	Inhibition of MARK2 conserved Lys2 (DLKAENLLLDADMNIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-40.6	CHEMBL3831	Homo sapiens	INH	%	-40.6
	18232179	CHEMBL4050327	Inhibition of human MARK2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	75.0	CHEMBL3831	Homo sapiens	Activity	%	75.0
	18253357	CHEMBL4054962	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	64.0	CHEMBL3831	Homo sapiens	Activity	%	64.0
	18253358	CHEMBL4054962	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	98.0	CHEMBL3831	Homo sapiens	Activity	%	98.0
	18265898	CHEMBL4057348	Inhibition of MARK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	18266092	CHEMBL4057542	Inhibition of MARK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-1.0	CHEMBL3831	Homo sapiens	INH	%	-1.0
	18275067	CHEMBL4118401	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-5.7	CHEMBL3831	Homo sapiens	INH	%	-5.7
	18275068	CHEMBL4118401	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-11.1	CHEMBL3831	Homo sapiens	INH	%	-11.1
	18275069	CHEMBL4118401	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-23.4	CHEMBL3831	Homo sapiens	INH	%	-23.4
	18275070	CHEMBL4118402	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDKTQLNSSSLQK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	2.5	CHEMBL3831	Homo sapiens	INH	%	2.5
	18275071	CHEMBL4118402	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDKTQLNSSSLQK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	6.3	CHEMBL3831	Homo sapiens	INH	%	6.3
	18275072	CHEMBL4118402	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAVKIIDKTQLNSSSLQK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	-8.1	CHEMBL3831	Homo sapiens	INH	%	-8.1
	18275073	CHEMBL4118403	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAENLLLDADMNIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-7.2	CHEMBL3831	Homo sapiens	INH	%	-7.2
	18275074	CHEMBL4118403	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAENLLLDADMNIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-8.4	CHEMBL3831	Homo sapiens	INH	%	-8.4
	18275075	CHEMBL4118403	Inhibition of MARK2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAENLLLDADMNIK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	3.6	CHEMBL3831	Homo sapiens	INH	%	3.6
	18282681	CHEMBL4120266	Inhibition of MARK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	35.0	CHEMBL3831	Homo sapiens	INH	%	35.0
	18282902	CHEMBL4120487	Inhibition of MARK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-5.3	CHEMBL3831	Homo sapiens	INH	%	-5.3
	18283122	CHEMBL4120707	Inhibition of MARK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-4.7	CHEMBL3831	Homo sapiens	INH	%	-4.7
	18440295	CHEMBL4157119	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	18449805	CHEMBL4178042	Inhibition of human MARK2 (2 to 691 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	134.0	CHEMBL3831	Homo sapiens	Activity	%	134.0
	18463775	CHEMBL4181191	Inhibition of recombinant human full length N-terminal His6-tagged PAR-1Balpha expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	6.0	CHEMBL3831	Homo sapiens	INH	%	6.0
	18484251	CHEMBL4185898	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	18484735	CHEMBL4185898	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	18507977	CHEMBL4191097	Inhibition of recombinant full-length human PAR-1Balpha at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	6.0	CHEMBL3831	Homo sapiens	INH	%	6.0
	18653457	CHEMBL4230175	Inhibition of PAR-1B-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	18653458	CHEMBL4230175	Inhibition of PAR-1B-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	18655437	CHEMBL4230798	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	91.0	CHEMBL3831	Homo sapiens	Activity	%	91.0
	18665433	CHEMBL4233375	Inhibition of PAR-1B (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL3831	Homo sapiens	IC50	nM	1000.0
	18751185	CHEMBL4263894	Inhibition of PAR-1B-ALPHA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	11.0	CHEMBL3831	Homo sapiens	INH	%	11.0
	18752010	CHEMBL4264387	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	18761551	CHEMBL4266602	Inhibition of recombinant human full length N-terminal His6-tagged PAR1BA expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	30.0	CHEMBL3831	Homo sapiens	INH	%	30.0
	18761822	CHEMBL4266602	Inhibition of recombinant human full length N-terminal His6-tagged PAR1BA expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	15.0	CHEMBL3831	Homo sapiens	INH	%	15.0
	18761985	CHEMBL4266602	Inhibition of recombinant human full length N-terminal His6-tagged PAR1BA expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-9.0	CHEMBL3831	Homo sapiens	INH	%	-9.0
	18858051	CHEMBL4307897	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	93.0	CHEMBL3831	Homo sapiens	Activity	%	93.0
	18892931	CHEMBL4314897	Inhibition of recombinant full-length human PAR1Balpha assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	95.5	CHEMBL3831	Homo sapiens	Activity	%	95.5
	18919552	CHEMBL4322908	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MARK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	6.0	CHEMBL3831	Homo sapiens	Kd	nM	6.0
	18919740	CHEMBL4322908	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MARK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	3.0	CHEMBL3831	Homo sapiens	Kd	nM	3.0
	18938059	CHEMBL4327756	Inhibition of human MARK2 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	94.46	CHEMBL3831	Homo sapiens	Activity	%	94.46
	18938060	CHEMBL4327756	Inhibition of human MARK2 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	97.04	CHEMBL3831	Homo sapiens	Activity	%	97.04
	18938601	CHEMBL4328120	Inhibition of human MARK2 assessed as residual activity at 100 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3831	Homo sapiens	Activity	%	65.0
	18938981	CHEMBL4328484	Inhibition of human MARK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.133	CHEMBL3831	Homo sapiens	IC50	10'-10M	1.33
	18958962	CHEMBL4333484	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	91.0	CHEMBL3831	Homo sapiens	Activity	%	91.0
	18964552	CHEMBL4335217	Inhibition of recombinant full-length human PAR1Balpha assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	105.0	CHEMBL3831	Homo sapiens	Activity	%	105.0
	18964553	CHEMBL4335217	Inhibition of recombinant full-length human PAR1Balpha assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	95.0	CHEMBL3831	Homo sapiens	Activity	%	95.0
	18972030	CHEMBL4337040	Inhibition of recombinant full-length human PAR1Balpha assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	85.0	CHEMBL3831	Homo sapiens	Activity	%	85.0
Not Active	19040088	CHEMBL4351992	Inhibition of recombinant full-length human PAR1Balpha at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3831	Homo sapiens	INH		
Active	19041171	CHEMBL4352432	Inhibition of human MARK2 at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3831	Homo sapiens	INH		
	19059675	CHEMBL4357976	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	19090240	CHEMBL4365814	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	19091993	CHEMBL4366467	Inhibition of human MARK2 isoform 4 at 100 nM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	1.93	CHEMBL3831	Homo sapiens	INH	%	1.93
	19114476	CHEMBL4371348	Binding affinity to MARK2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	4455.0	CHEMBL3831	Homo sapiens	Kd(free)	uM	4.455
	19114713	CHEMBL4371348	Binding affinity to MARK2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	7086.0	CHEMBL3831	Homo sapiens	Kd(free)	uM	7.086
	19144734	CHEMBL4377750	Inhibition of recombinant full-length human PAR1Balpha at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	2.0	CHEMBL3831	Homo sapiens	INH	%	2.0
	19146894	CHEMBL4378898	Inhibition of recombinant full-length human PAR1Balpha at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1	Outside typical range	CHEMBL4459587	=	Inhibition	%	-13.0	CHEMBL3831	Homo sapiens	INH	%	-13.0
	19147976	CHEMBL4379296	Inhibition of recombinant full-length human PAR1Balpha using KKKVSRSGLYRSP as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3831	Homo sapiens	IC50	uM	10.0
	19159503	CHEMBL4382607	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	57.0	CHEMBL3831	Homo sapiens	Activity	%	57.0
	19191504	CHEMBL4389326	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	41.0	CHEMBL3831	Homo sapiens	INH	%	41.0
	19191989	CHEMBL4389803	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	69.0	CHEMBL3831	Homo sapiens	INH	%	69.0
	19200245	CHEMBL4391429	Binding affinity to wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	46.0	CHEMBL3831	Homo sapiens	Activity	%	46.0
	19266490	CHEMBL4405440	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3831	Homo sapiens	INH	%	50.0
	20600588	CHEMBL4603540	Inhibition of recombinant full length human GST-tagged MARK2 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3831	Homo sapiens	IC50	uM	100.0
	22423485	CHEMBL4674318	Inhibition of human MARK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	70.69	CHEMBL3831	Homo sapiens	Activity	%	70.69
	22423486	CHEMBL4674318	Inhibition of human MARK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	2.81	CHEMBL3831	Homo sapiens	Activity	%	2.81
	22843682	CHEMBL4720668	Inhibition of human MARK2 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.148	CHEMBL3831	Homo sapiens	IC50	10^-10M	1.48
	22844032	CHEMBL4721018	Inhibition of human MARK2 assessed as residual activity using KKKVSRSGLYRSPSMPENLNRPR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.99	CHEMBL3831	Homo sapiens	Activity	%	97.99
	22844782	CHEMBL4721457	Inhibition of wild-type human partial length MARK2 (M1 to R450 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	96.02	CHEMBL3831	Homo sapiens	Activity	%	96.02
Not Active	22909946	CHEMBL4734076	Inhibition of recombinant human full length GST-tagged MARK2 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate at 10 uM by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL3831	Homo sapiens	INH		
Not Active	22909947	CHEMBL4734076	Inhibition of recombinant human full length GST-tagged MARK2 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate at 10 uM by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL3831	Homo sapiens	INH		
Not Active	22909948	CHEMBL4734076	Inhibition of recombinant human full length GST-tagged MARK2 expressed in baculovirus expression system using serine/threonine-21 peptide as substrate at 10 uM by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL3831	Homo sapiens	INH		
	22952941	CHEMBL4766878	Inhibition of recombinant full-length human PAR1Balpha assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	92.0	CHEMBL3831	Homo sapiens	Activity	%	92.0
	23120656	CHEMBL4804426	Inhibition of MARK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	2900.0	CHEMBL3831	Homo sapiens	IC50	uM	2.9
	23120657	CHEMBL4804426	Inhibition of MARK2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-7800.0	CHEMBL3831	Homo sapiens	IC50	uM	-7.8
	23120658	CHEMBL4804426	Inhibition of MARK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-17300.0	CHEMBL3831	Homo sapiens	IC50	uM	-17.3
	23120659	CHEMBL4804426	Inhibition of MARK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	9300.0	CHEMBL3831	Homo sapiens	IC50	uM	9.3
	23120660	CHEMBL4804426	Inhibition of MARK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-17200.0	CHEMBL3831	Homo sapiens	IC50	uM	-17.2
	23120661	CHEMBL4804426	Inhibition of MARK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	40700.0	CHEMBL3831	Homo sapiens	IC50	uM	40.7
	23121695	CHEMBL4804608	Inhibition of MARK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	23121696	CHEMBL4804608	Inhibition of MARK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	23121697	CHEMBL4804608	Inhibition of MARK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	23121698	CHEMBL4804608	Inhibition of MARK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	23121699	CHEMBL4804608	Inhibition of MARK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL3831	Homo sapiens	INH	%	0.0
	23121700	CHEMBL4804608	Inhibition of MARK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	<=	Inhibition	%	75.0	CHEMBL3831	Homo sapiens	INH	%	75.0
	23122661	CHEMBL4805012	Inhibition of human MARK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	23123356	CHEMBL4805600	Inhibition of human MARK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	23123815	CHEMBL4806059	Inhibition of DNA-tagged human MARK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	75.0	CHEMBL3831	Homo sapiens	Activity	%	75.0
	23124802	CHEMBL4806617	Inhibition of human MARK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3831	Homo sapiens	Activity	%	100.0
	23124803	CHEMBL4806617	Inhibition of human MARK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL3831	Homo sapiens	Activity	%	96.0
	23128275	CHEMBL4807900	Inhibition of MARK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3831	Homo sapiens	Activity	%	75.0
	23128276	CHEMBL4807900	Inhibition of MARK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3831	Homo sapiens	Activity	%	75.0
	23128277	CHEMBL4807900	Inhibition of MARK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3831	Homo sapiens	Activity	%	75.0
Not Active	23317496	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23317964	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23318631	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	95.0	CHEMBL3831	Homo sapiens	% Control	%	95.0
Not Active	23319114	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23319751	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23320226	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23320904	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23321372	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23322002	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	88.0	CHEMBL3831	Homo sapiens	% Control	%	88.0
Not Active	23322470	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	92.0	CHEMBL3831	Homo sapiens	% Control	%	92.0
Not Active	23323159	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	92.0	CHEMBL3831	Homo sapiens	% Control	%	92.0
Not Active	23323627	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23324086	CHEMBL4880705	PAR-1Balpha (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	26.0	CHEMBL3831	Homo sapiens	% inhibition	%	26.0
Not Active	23324481	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23325116	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23325584	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23326231	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	59.0	CHEMBL3831	Homo sapiens	% Control	%	59.0
Not Active	23326699	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23327399	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23327867	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	63.0	CHEMBL3831	Homo sapiens	% Control	%	63.0
Not Active	23328454	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	97.0	CHEMBL3831	Homo sapiens	% Control	%	97.0
Not Active	23328922	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23329462	CHEMBL4881169	PAR-1Balpha (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	113.0	CHEMBL3831	Homo sapiens	% residual kinase activity	%	113.0
Not Active	23329868	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23330336	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23331092	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23331560	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23332147	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23332613	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23333331	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23333970	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	99.0	CHEMBL3831	Homo sapiens	% Control	%	99.0
Not Active	23334438	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23334926	CHEMBL4881549	PAR-1Balpha (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	33.0	CHEMBL3831	Homo sapiens	% inhibition	%	33.0
Not Active	23335417	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23335885	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23336512	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	89.0	CHEMBL3831	Homo sapiens	% Control	%	89.0
Not Active	23336980	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	97.0	CHEMBL3831	Homo sapiens	% Control	%	97.0
Not Active	23337676	CHEMBL4882047	MARK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.5	CHEMBL3831	Homo sapiens	% Ctrl	%	98.5
Not Active	23338061	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23338529	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	92.0	CHEMBL3831	Homo sapiens	% Control	%	92.0
Not Active	23339141	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	78.0	CHEMBL3831	Homo sapiens	% Control	%	78.0
Not Active	23339609	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23340246	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23340714	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	75.0	CHEMBL3831	Homo sapiens	% Control	%	75.0
Not Active	23341371	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23341839	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23342455	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23342923	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23343271	CHEMBL4882456	MARK2 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	107.0	CHEMBL3831	Homo sapiens	% Ctrl	%	107.0
Not Active	23343553	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23344021	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23344659	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23345232	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23345700	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	81.0	CHEMBL3831	Homo sapiens	% Control	%	81.0
Not Active	23346277	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23346745	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23347091	CHEMBL4882618	Invitrogen kinase screen (MARK2)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1	Non standard unit for type	CHEMBL4538174		IC50	M	1.4	CHEMBL3831	Homo sapiens	IC50	M	1.4
Not Active	23347347	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23347837	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23348416	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23348884	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23349471	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23350089	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23350557	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	93.0	CHEMBL3831	Homo sapiens	% Control	%	93.0
Not Active	23351162	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23351630	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23352128	CHEMBL4882817	MARK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	7.826	CHEMBL3831	Homo sapiens	% Inhibition	%	7.8264
Not Active	23352654	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23353122	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	89.0	CHEMBL3831	Homo sapiens	% Control	%	89.0
Not Active	23354004	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23354472	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23355204	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23355672	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23356308	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23356776	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23357385	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	80.0	CHEMBL3831	Homo sapiens	% Control	%	80.0
Not Active	23358032	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23358500	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	80.0	CHEMBL3831	Homo sapiens	% Control	%	80.0
Not Active	23359086	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23359684	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23360152	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23360737	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23361205	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	74.0	CHEMBL3831	Homo sapiens	% Control	%	74.0
Not Active	23361778	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23362314	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	89.0	CHEMBL3831	Homo sapiens	% Control	%	89.0
Not Active	23362782	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	69.0	CHEMBL3831	Homo sapiens	% Control	%	69.0
Not Active	23364424	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23364892	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23365631	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23366174	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23366764	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	65.0	CHEMBL3831	Homo sapiens	% Control	%	65.0
Not Active	23367232	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23367634	CHEMBL4883987	MARK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	105.0	CHEMBL3831	Homo sapiens	% Residual activity with Skepinone-L	%	105.0
Not Active	23368110	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	90.0	CHEMBL3831	Homo sapiens	% Control	%	90.0
Not Active	23368578	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	82.0	CHEMBL3831	Homo sapiens	% Control	%	82.0
Not Active	23369177	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23369645	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	68.0	CHEMBL3831	Homo sapiens	% Control	%	68.0
Not Active	23370180	CHEMBL4884422	PAR-1Balpha(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	32.0	CHEMBL3831	Homo sapiens	% residual kinase activity	%	32.0
Slightly Active	23370613	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	40.0	CHEMBL3831	Homo sapiens	% Control	%	40.0
Not Active	23371081	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL3831	Homo sapiens	% Control	%	99.0
Not Active	23371890	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23372358	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
	23372809	CHEMBL4884774	MARK2(MAR2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3831	Homo sapiens	pIC50		6.0
	23373218	CHEMBL4885065	MARK2(MAR2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3831	Homo sapiens	pIC50		6.0
	23373576	CHEMBL4885353	MARK2(MAR2LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3831	Homo sapiens	pIC50		6.0
Not Active	23375288	CHEMBL4886270	MAP/microtubule affinity-regulating kinase 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	9.0	CHEMBL3831	Homo sapiens	% inhibition	%	9.0
Not Active	23375785	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	71.0	CHEMBL3831	Homo sapiens	% Control	%	71.0
Not Active	23376253	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	78.0	CHEMBL3831	Homo sapiens	% Control	%	78.0
Not Active	23376830	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	78.0	CHEMBL3831	Homo sapiens	% Control	%	78.0
Not Active	23377298	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	92.0	CHEMBL3831	Homo sapiens	% Control	%	92.0
Not Active	23378158	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23378626	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23379793	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23380261	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23380955	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	91.0	CHEMBL3831	Homo sapiens	% Control	%	91.0
Not Active	23381603	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23382071	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	85.0	CHEMBL3831	Homo sapiens	% Control	%	85.0
Not Active	23382695	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	66.0	CHEMBL3831	Homo sapiens	% Control	%	66.0
Slightly Active	23383163	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	47.0	CHEMBL3831	Homo sapiens	% Control	%	47.0
Not Active	23383882	CHEMBL4887501	MARK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	90.0	CHEMBL3831	Homo sapiens	% Ctrl	%	90.0
Not Active	23383883	CHEMBL4887501	MARK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	87.0	CHEMBL3831	Homo sapiens	% Ctrl	%	87.0
Not Active	23384394	CHEMBL4887989	PAR-1Balpha(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	6.75	CHEMBL3831	Homo sapiens	% inhibition	%	6.75
Not Active	23384673	CHEMBL4888199	MARK2 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	-2.0	CHEMBL3831	Homo sapiens	% Inhibition	%	-2.0
Not Active	23385078	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
Not Active	23385545	CHEMBL4879802	KinomeScan assay: inhibition of MARK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3831	Homo sapiens	% Control	%	100.0
